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ABSlRACf 
A leucine-inserting tRNA has been transformed into a serine-inserting tRNA by 
changing 12 nucleotides. Only 8 of the 12 changes are required to effect the conversion of 
the leucine tRNA to serine tRNA identity. The 8 essential changes reside in basepair 11-24 
in the D stem, basepairs 3-70, 2-71 and nucleotides 72 and 73, all of the acceptor stem. 
t ' 
Functional amber suppressor tRNA genes were generated for 14 species of tRNA in 
E. coli, and their amino acid specificities determined. The suppressors can be classified 
into three groups, based upon their specificities. Class I suppressors, tRNAAla2cuA, 
tRNA GlyUCUA• tRNAHisACUA, tRNALysCUA, and tRNAProHCUA, inserted the predicted 
amino acid. The Class II suppressors, tRNA GluACUA , tRNA GlyT CUA, and tRNAllelCUA 
were either partially or predominantly mischarged by the glutamine aminoacyl tRNA 
synthetase (AAS). The Class III suppressors, tRNAAr&cuA, tRNAAspMcuA, tRNAlle2cuA, 
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BACKGROUND 
In the translation of genetic information from nucleic acid to protein, transfer RNA plays a 
crucial intermediate role. Each codon is read by a unique tRNA that has been 
aminoacylated with the appropriate amino acid. Because of degeneracy in the genetic code, 
in general there is more than one tRNA for each amino acid (1). Although there are some 
exceptions to the rule, there is a single aminoacyl tRNA synthetase (AAS) for each amino 
acid. An AAS must correctly recognize and activate an amino acid and then join it to each 
of the cognate set of tRNAs. By virtue of the fact that they must function interchangeably 
on the ribosome during protein synthesis, all tRNAs have similar primary (2), secondary 
(3), and tertiary (4, 5) structures (Figure 1). Within these constraints each cognate set of 
tRNAs contains distinct elements that mediate correct recognition by the AAS. These 
elements comprise the identity of a tRNA. Identity elements can be both positive and 
negative. Positive elements are those features of the tRNA that the cognate AAS recognizes 
directly, and negative elements are those features that block the recognition by other AASs. 
Although tRNAs comprise a homogeneous set of molecules, AASs are remarkably 
diverse. The quaternary structures a, az, a... and az~ have all been observed (6, 7). AAS 
subunit sizes range from 300 to 900 amino acids. The details of the interaction between 
these diverse enzymes and their tRNA substrates will not be known until high resolution 
X-ray structures of tRNA-AAS complexes have been solved. Fortunately, there is the 
prospect that several such complexes will be solved in the near future (8, 9). Already, we 
have a remarkably detailed description of the amino acid and A TP binding sites for the B. 
stearothermophilus tyrosine AAS (10) and the E. coli methionine AAS (11). It is not our 
purpose to review the large body of information on the structure and properties of the AAS, 
or on the indirect efforts that have been employed to map their interactions with tRNA. 
These have been well reviewed before in these volumes (6, 7). Rather, we wish to 
describe the results of fresh and energetic approaches to the problem of tRNA identity, 
which have appeared in the last few years. 
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Past and Present Approaches to Defining tRNA Identity. 
We will describe two new approaches to the determination oftRNA identity. Both have 
their roots in previous work but are now more powerful because of advances in gene 
synthesis technology. In the first, attempts are made to alter with the fewest changes, the 
identity of a tRNA while retaining complete biological function. Those changes 
responsible for the redirection of AAS recognition constitute identity eiements. We term 
this type of experiment an identity swap. In the second, tRNA variants are generated by 
altering the sequence of a tRNA, and their properties as a substrate for the AAS are 
determined in vitro. This approach has been greatly facilitated by the ability to synthesize 
tRNA in vitro with bacteriophage TI RNA polymerase. 
The identity swap has its origins in the study of amber suppressors. An amber 
suppressor is a mutant tRNA that can recognize and suppress the chain terminating effects 
of a UAG codon, by virtue of a change in the tRNA's anticodon (12, 13). Suppressors 
have greatly facilitated the application of genetics to the study of tRNA, and have been 
utilized extensively in bacteria (14), T4 bacteriophage (15, 16), and yeast (17). Such work 
has led to a formal proof of the secondary structure of tRNA (14) and to information about 
the mechanism oftRNA processing (18-20). Suppressors have also been used to address 
the tRNA identity problem. Attempts were made to alter the specificity of the E. coli 
tRNA Tyr suppressor, su+3, by selecting mutants of this tRNA that could suppress amber 
mutations at positions in which tyrosine was not an acceptable amino acid. This approach 
was taken independently by J. D. Smith and S. Brenner in Cambridge and by H. Ozeki and 
Y. Shimura in Kyoto nearly 20 years ago (21, 22). Both groups obtained the same results. 
The su+3 mutants that were isolated inserted glutamine instead of tyrosine into amber 
codons (23). Sequence analysis revealed changes in the fourth base from the 3' end, 
A72_, G (22) and in the first and second base pairs of the acceptor stem 1-72 and 2-71 
(21). This was an exciting result, but it did not prove to be universally applicable to the 
study of tRNA identity. Despite many attempts, su+3 mutants that inserted an amino acid 
other than glutamine or tyrosine were never found (23). It is likely that such 
transformations would have required more than one change in the tRNA sequence and 
therefore could not be obtained by genetic selection. This approach was abandoned for 
fifteen years. 
We have returned to this approach armed with an automated DNA synthesizer, 
which allows the rapid synthesis of altered suppressors de novo, as in the pioneering work 
of Khorana (24). The synthetic genes are assembled from oligonucleotides and inserted in 
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cassette form into a plasmid, which supplies a promoter, either the inducible lac promoter 
(25) or the constitutive lpp promoter (26, 27), and a transcription terminator. Usually a 
screen is employed, in which the suppression of an amber mutation in a gene requires the 
insertion of a specific amino acid to allow growth. The amino acid specificity of the 
suppressor is determined by sequencing the protein product of a suppressed amber mutant 
gene. For this purpose the E. coli dihydrofolate reductase (DHFR) gene with an amber 
mutation at codon ten is used. DHFR is easily purified by affinity chromatography on a 
methotrexate resin. X-ray crystallographic data (28-29) revealed that residue ten of DHFR 
lies on the surface of the protein, well removed from the active site, and it appears that any 
amino acid is acceptable at this position. If more than one amino acid is inserted by the 
suppressor, it can be readily detected by this method. Protein sequence data acquired in 
this manner reveal the outcome of the competition among all 20 AAS in the cell for the 
suppressor. The drawbacks to this method are twofold. First, the anticodon of the tRNA 
must be CUA to allow recognition of amber codons; so the contribution of the anticodon to 
tRNA identity cannot be assessed. As described below, the anticodon is a strong identity 
element for some tRNAs. Second, the effectiveness of the suppressor tRNA as a substrate 
for the AAS can only be measured by the efficiency of suppression. Multiple factors, such 
as the ability of the tRNA to be transcribed, processed, modified, and accepted by the 
ribosome, can affect the observed suppression efficiency, and in this method cannot be 
distinguished from the efficiency of aminoacylation. 
In the second method developed by Uhlenbeck (30), tRNA genes and their variants 
are synthesized and placed under the control of the bacteriophage 17 promoter so that the 
first nucleotide of the in vitro transcript is the mature 5' end of the tRNA. Alternatively, 
synthetic tRNAs with 5' precursor sequences can be processed correctly by incubation with 
the RNA component of RNAse P (31; L. Schulman, unpublished). A Bst Nl restriction 
endonuclease recognition site (5'CC·AGG) is encoded at the 3' end of the gene. Run-off 
transcription ofBst Nl cleaved DNA generates the correct CCA terminus. Prior to the 
availability of this methodology, the study of tRNA was hindered in that most variants 
were not processed or were unstable in vivo. This technique not only overcomes such 
obstacles but also allows the easy purification of the transcript. Reactions can be scaled up 
and milligrams of some transcripts have been produced for NMR studies (Hall et al, 
unpublished). These synthetic tRNAs do not contain the normal base modifications found 
in native tRNA (and are therefore excellent substrates for the study of any modifying 
enzyme). They are, nonetheless, good substrates for the AAS. Typically, the Kro values 
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for the substrates are one- to four-fold higher than for fully modified tRNA. V max values 
for the unmodified substrates are at most, two-fold lower, resulting in values of the 
specificity constant (k:cat!Krn) that are five- to seventeen-fold lower. In contrast, the 
kcat!Krn for a typical misacylation is orders of magnitude lower (6). These results indicate 
that the modified nucleotides are not likely to play a large role in recognition by the AAS, as 
their absence does not significantly diminish the efficiency of aminoacylation. 
In order to determine that the synthetic tRNAs are properly folded, Sampson and 
Uhlenbeck (32) have exploited the phenomenon of lead-mediated cleavage of tRNA. This 
reaction is mediated by a tightly bound Pb++ ion whose position is determined by the 
tertiary interactions between the D-loop and T-loop (33, 34). In native yeast tRNAPhe, 
cleavage takes place at residue 17. Unmodified tRNAPhe is ~l.eaved at the same position, 
with similar kinetics, indicating that the synthetic molecule has folded properly. The in 
vitro approach is attractive in that one can quantitate the effects of individual nucleotide 
changes on the recognition of the tRNA by cognate and non-cognate AAS. The method 
does not allow assessment of the effect of competition between one AAS and the other 19 
AASs. In the end, it will be desirable to apply both the in vivo and in vitro approaches to 
determine the identity elements of any tRNA. 
The Role of the Anticodon in tRNA Identity. 
Since the anticodon is directly correlated with the identity of any tRNA species, it is the 
most logical identity element. Indeed, one of the earliest recognition hypotheses stated that 
the "coding triplet (anticodon) plays an important, perhaps decisive role in the interaction 
with the synthetase" (35). Early evidence to support this hypothesis came from a 
combination of chemical modification and oligonucleotide interference experiments as well 
as from analysis of mutant tRNAs, and suggested that for a number of tRNAs, the 
anticodon can be implicated in recognition. Among them are E. coli tRNAGly, tRNALys. 
tRNAArg, tRNAGlu, tRNAMet(t), tRNATrp, yeast tRNAGly, tRNAVal, and beef pancreatic 
tRNATrp (reviewed in 36). 
The opposing notion, that the anticodon could not be a recognition element, was 
derived from the observation that the anticodon could be altered to create amber 
suppressors with no effect on amino acid specificity in at least four tRNAs. Additionally, 
translation of the codons (six each) for serine, leucine, and arginine requires a set of tRNAs 
with different nucleotides in two out of three positions for leucine and arginine, and in all 
three for serine. The idea that the anticodon is not an identity element seems to have held 
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sway, in some quarters at least, because a few textbooks still state this unequivocally. 
Nonetheless, it is now clear that the anticodon is a recognition element for tRNA identity in 
perhaps a majority of tRNAs. 
The strongest evidence in support of this view comes from L. Schulman's work on 
E. coli tRNAMet. Experiments conducted over a period of 15 years have demonstrated 
conclusively that the CAU anticodon of E. coli tRNAMet is an essential recognition element 
for the methionine AAS. Chemical modification experiments have shown that the 
anticodon nucleotides C34 and A35 cannot be modified without loss of methionine acceptor 
activity in vitro (37). The anticodon of tRNAMet was altered by the judicial insertion of 
oligoribonucleotides into the tRNA, which had been cleaved specifically by RNAse. These 
experiments revealed that substitution of~ with aU, A, or G lead to a decrease in the 
aminoacylation rate by four to five orders of magnitude (38). Altering the other two 
positions of the anticodon (A35 and U36) affect AAS recognition as well, decreasing the 
rate of aminoacylation one to four orders of magnitude to that of normal (39). 
Substitutions of any position in the anticodon with nucleotides containing functional groups 
in common with those of the wildtype nucleotides were tolerated more than if nucleotides, 
lacking similar functional groups were substituted The conclusion was that the synthetase 
must be interacting with specific functional groups in the anticodon (40). In addition, 
chemical crosslinking experiments demonstrated that C34 of the anticodon is uniquely 
crosslinked to Lys 465 in the methionine AAS (41). 
More recently, Schulman has conducted identity swap experiments in the in vitro 
system (42). In these experiments genes for both tRNATrp and tRNAVal of E. coli were 
synthesized with the methionine (CAU) anticodon, transcribed in vitro, and the kinetics of 
acylation by the methionine AAS and valine AAS were determined for the synthetic tRNAs 
(Table 1). tRNAVal (CAU) was aminoacylated by the methionine AAS with a VmaxfKrn 
similar to native tRNAMet. tRNATrp (CAU) was also acylated by the methione AAS, but 
the Vmax!Krn was down ten-fold. Conversely, tRNAMet with the valine anticodon (UAC) 
was acylated by the valine AAS with a V max!Km value 1/10 of that for normal tRNA Val. In 
comparison, the value for acylation of tRNAMet by the valine AAS was four orders of 
magnitude lower than that for tRNAVal. These results clearly show that the anticodon is a 
major, if not the sole, recognition element for tRNAMet and is important for tRNA Val 
identity as well. 
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Theories about the role of the anticodon in AAS recognition have generally been 
influenced by the existence and the properties of amber suppressors. The demonstration 
that suppressors for tRNATYT, tRNA5er, tRNA0 ln, tRNALeu, were correctly charged, 
indicated that not all AASs recognize the anticodon nucleotides of their cognate tRNAs. A 
more complete picture of the effects of the amber anticodon on AAS recognition has been 
obtained from our efforts in collaboration with J. Miller and coworkers to construct a 
complete bank of 20 amber suppressors (27, 43 Normanly eta/, unpublished). These 
suppressors have been generated by synthesizing the genes of isoacceptors from the 20 
species oftRNA in E. coli, each containing a CUA anticodon. As in the identity swap 
experiments described above, the tRNA genes are inserted in cassette form into a plasmid 
containing the constitutive lpp promoter and a terminator. The amino acid specificity of 
each suppressor was determined as described above by sequencing the suppressed product 
of the amber mutation at position ten in DHFR. Tables 2 and 3 give a summary progress 
report of this project. Table 2 lists the species of tRNA, which exist as amber alleles, 
derived either genetically or by synthetic means. Table 3 classifies the suppressors by their 
amino acid specificity. Seven of the synthetic suppressors insert the correct amino acid. 
Together with the four original suppressors, 11 of 20 tRNAs in E. coli can tolerate the 
amber anticodon without misacylating. In some cases suppressor tRNAs are mischarged 
by the glutamine AAS. The synthetically derived tRNAG1t1AcuA inserts 20% glutamine. 
From previous work (44) we know that tRNAMet(f)CUA is mischarged by the glutamine 
AAS in vitro, and the su+? allele of tRNA Ttp inserts a mixture of glutamine and tryptophan 
in vivo (45). The amber allele of one isoacceptor of tRNAGIY, tRNA01YUcuA. was correctly 
charged in vivo, another tRNAGlyTCUA• was misacylated by the glutamine AAS (46; 
Normanly eta/, unpublished). We were surprised to fmd that six of the suppressors 
generated in this work, tRNAArgCUA, tRNAAspMCUA, tRNAlle2cuA, tRNAMet(m)CUA, 
tRNA Thr2CUA and tRNA VaiCUA• were misacylated by the lysine AAS. There are also 
examples of suppressors that are misacylated by both the glutamine and lysine AASs. 
Such is the case for tRNAilelcuA, as well as for some mutant suppressor tRNAs (46-48). 
Apparently, only the glutamine AAS and the lysine AAS rnisacylate amber 
suppressors. Each tends to misacylate a separate set Because the CUA anticodon is 
recognized by both the glutamine AAS and the lysine AAS, there must be negative elements 
that prevent acylation by these enzymes. Some suppressors have both elements, some only 
one, and others have neither. It is interesting to note that there are two lysine AAS genes in 
E. coli, one of which is preferentially expressed during heat shock (49). Preliminary 
8 
experiments designed to detect which of the enzymes is responsible for the observed 
misacylation indicated that both are. 
A Single Base Pair is a Major Identity Detenninantfor tRNAAID. 
Hou and Schimmel set out to isolate mutants of a tRNAAla amber suppressor, which could 
not be recognized by the alanine AAS using the in vivo approach (50). An impressive 
collection of synthetic mutants was generated with multiple changes throughout the tRNA. 
Only those mutants having in common a change in the G-U pair at position 3-70 failed to 
insert alanine. This fmding is consistent with two previous observations. First, earlier 
work by Murgola had indicated that a G-U pair at this position in a tRNALys missense 
suppressor caused the insertion of either alanine or glycine (51). Second, the G-U pair at 
this position is conserved in virtually all of the tRNAAla that have been sequenced. To test 
the significance of the G3-U70 pair, Hou and Schimmel performed two identity swap 
experiments. tRNACys and tRNAPhe amber suppressors were synthesized, each containing 
the G-U pair at position 3-70. The altered cysteine suppressor inserted entirely alanine 
(fable 4). The altered phenylalanine suppressor inserted predominately alanine (63%) and 
some phenylalanine (37% ). This result is certainly one of the most dramatic identity shift 
experiments to date in that it implicated a single G-U pair as the major identity element for 
the alanine AAS. 
The ability of the G3-U70 pair to direct alanine AAS recognition has been tested in 
other tRNAs with mixed results. Superimposing the G-U pair at position 3-70 of a lysine 
suppressor results in complete conversion to alanine identity (48). However, the same 
alteration to a glycine suppressor tRNA (GlyT) results in the insertion of predominantly 
glutamine, a small amount of glycine, and no detectable levels of alanine (46). It shoud be 
noted that the glycine amber suppressor with the normal G-C base pair at position 3-70 
inserts predominantly glutamine (46; Normanly et al, unpublished). In the case of 
tRNAGiyT, simply superimposing the G-U pair at position 3-70 is not sufficient to 
counteract the identity determinants for the glutamine AAS. The glycine to alanine identity 
swap experiment might be more successful if the amber allele of another isoacceptor of 
tRNA Giy which is not misacylated, were used instead. 
McClain and Foss approached the problem of tRNAAla from a different angle ( 46). 
McClain has developed an algorithm (52, 53), which compares the sequences of a tRNA 
with its isoacceptors as well as isoacceptors of all 19 other tRNAs. This algorithm selects 
those positions in a tRNA, which are correlated with its isoacceptors and anticorrelated 
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with the other tRNA sequences. Subjecting tRNAAla to this type of analysis resulted in the 
prediction that four nucleotides were significant to tRNAAla in addition to the anticodon. 
These were the GrU70 pair, as well as G20 and C60 (Figure 2). The phenylalanine 
suppressor was altered to include these nucleotides, and a change was incorporated at 
position 51 to increase transcriptional efficiency (54). They also made changes at positions 
16 and 17, which were designed to remove phenylalanine identity. In the DHFR assay, the 
resulting suppressor inserted 96% alanine and 4% lysine, indicating that the phenylalanine 
identity determinants had been removed. 
They examined the contribution of C60 to alanine identity, and found that altering 
this putative identity element in tRNAAla did not abolish alanine acceptance, nor did it give 
rise to acylation by the alanine AAS when superimposed upon tRNAPhe. In a similar 
fashion, the contribution of G20 to alanine identity was determined to be minimal. Alanine 
acceptance was not abolished when G20 was altered in tRNAAla, nor did G20 transplanted 
into tRNAPhe result in alanine insertion. It would appear that these elements of alanine 
identity predicted by the algorithm do not have a strong effect upon alanine AAS 
recognition. 
tRNAPhecontaining the G3-U70 base-pair alone, inserted 24% alanine and 76% 
phenylalanine. This result was the inverse of that obtained by Hou and Schimmel (63% 
alanine and 37% phenylalanine). The reason for this discrepancy is not clear, because both 
groups used the same expression system and the same specificity assay; namely, 
suppression of an amber mutation in DHFR. In any case, the G3-U70 pair is clearly the 
dominant determinant of Ala identity, and is the strongest contributor to alanine identity 
predicted by McClain's algorithm. 
The G-U pair as an identity element raises an interesting question. Does the alanine 
AAS recognize the functional groups of these bases via interactions in the deep groove of 
the A-helix or is it the perturbations to the helix stability and structure imposed by the G-U 
"wobble" pair that are recognized? To answer this question McClain has now constructed 
alanine suppressors that contain each of 16 possible base combinations at position 3-70 
(48). All the variants had substantially lowered suppression efficiencies, and some of the 
base combinations yielded inactive suppressors. The four Watson-Crick base pairs at this 
position yielded suppressors that inserted lysine and glutamine. tRNAAla containing the 
mispairs G-A, C-A, and U-U at position 3-70 all inserted 90% alanine and, though less 
efficient, were similar to G-U at this position. Other variants, containing A-C and C-C, 
C-U or U-G at position 3-70 inserted -80% alanine, along with lysine and glutamine. The 
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mispairs, G-G, A-A, and A-G led to inactive suppressors, and the variant with a U-C 
mispair inserted predominantly glutamine. These results suggest that the alanine AAS is 
recognizing a structural perturbation imparted by the G-U pair and not specific bases. 
However, not all mispairs are acceptable; so the perturbation that is recognized must be 
sequence dependent. (It should be noted that NMR and X-ray crystallographic data reveal 
that a G-U base pair does not have a dramatic effect upon the overall structure of the 
acceptor stem helix.) Translocation of the G-U pair to position 4-69led to partial alanine 
insertion, but only if the 3-70 pair was A-U and not G-C. G-U at position 2-71 had no 
activity. More questions are raised by these observations than are answered. The results 
emphasize the fact that there is insufficient data on the sequence dependence of RNA 
structure. Among the structural variations that one can imagine is a bending of the helix or 
even a separation of the strands. 
The tRNALeu--+Ser Identity Swap. 
We have used the suppressor approach to define the elements of tRNASer identity (25). 
Serine was chosen for several reasons. There are six serine codons, AGU/C and UCN 
(where N denotes any nucleotide) recognized by at least four different tRNAs. One of the 
original amber suppressors (su+t) inserted serine; so in all, the serine AAS can recognize 
tRNAs with at least five anticodons. It is unlikely that there are any serine recognition 
elements in the anticodon although this assumption has not yet been tested in vitro. We set 
out to change the identity of a tRNA Leu amber suppressor to serine. An examination of the 
six E. coli tRNASer sequences revealed fourteen nucleotides conserved in all tRNASer 
sequences but not found in the tRNALeus starting sequence. Additionally, the base pair at 
position 3-70, though not conserved (A-U or U-A) was found by McClain's statistical 
analysis to be correlated with serine and anticorrelated with other sequences (52, 53). This 
base pair was included as a potential element of serine AAS recognition (Figure 3a). The 
conserved nucleotides in the acceptor stem and in the D-stem and loop were included in the 
original trial construction. In addition, the size of the D-loop is highly conserved in the six 
tRNASer sequences. Changes were made in that region to conform to the serine D-loop 
size. The first trial construction contained 12 changes from the starting tRNALeu5 amber 
suppressor (Figure 3b). The resultant suppressor, tRNALeu-+Ser. was able to suppress an 
amber mutation in the f3-lactamase gene, which requires the insertion of serine to produce 
an active enzyme. However, the suppression efficiency of tRNAl.eu-+Ser, 1%, was quite 
low compared to the 60 to 100% efficiency of the starting tRNALeu suppressor. Using the 
11 
DHFR assay, the amino acid specificity of the tRNALeu~ser suppressor was determined to 
be serine. 
Following our initial successful attempt at the identity swap, we then set out to 
determine the minimum number of changes required to effect the transformation. This has 
now been accomplished and the results are shown in Figure 3c. The minimum number of 
base changes required is eight: residing in the first three base pairs of the acceptor stem, 
nucleotide 73 and the 11-24 base pair in the D-stem. The resulting suppressor containing 
these minimal changes is approximately 40% efficient The efficiency was regained when 
the unnecessary changes in the D-loop were discarded. Interestingly, we find that only an 
A-U is acceptable at position 3-70 even though some serine tRNAs contain U-A at this 
position. We speculate that the A-U is acting as a deterrant to the leucine AAS. We are 
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now using this information to conduct further identity swaps: Perhaps other serine identity 
elements exist that were already present in tRNALeus. By this iterative procedure we hope 
to arrive at a clear understanding of tRNASer identity. The E. coli serine AAS has been 
purified and crystallized by R. Leberman in Grenoble (55). The ultimate understanding of 
tRNASer recogniton will come when the manner in which these identity elements are 
recognized by the enzyme has been defined. 
tRNAPiu Recognition. 
As in the case of E. coli tRNAMet, the anticodon has been implicated in the recognition of 
yeast tRNAPhe by the yeast phenylalnine AAS. Early work by Zachau, in which the 
anticodon of yeast tRNAPhe was removed, resulted in a tRNA that was aminoacylated by 
the phenylalnine AAS at a level20% that of wildtype tRNAPhe (55a). Using recombinant 
RNA technology, Uhlenbeck and co-workers have demonstrated that substitution of any of 
the yeast tRNAPhe anticodon nucleotides diminishes aminoacylation (kcat/Km was 
decreased 3- to 10-fold) (56). In addition, transplanting the phenylalanine anticodon onto 
tRNA Tyr leads to aminoacylation of the hybrid molecule by the phenylalnine AAS (57). As 
the aminoacylation of the hybrid tRNA was fairly weak, they speculated that there must be 
phenylalanine recognition elements outside of the anticodon as well. 
Using the in vitro system, transcription of synthetic tRNA genes with 17 RNA 
polymerase, a large number of variants have been constructed and their properties as 
substrates have been tested (30, 58). This is by far the largest and most comprehensive set 
of tRNA variants ever constructed. At this point nearly all of the non-universal bases in 
tRNAPhe have been changed and the variants have been tested as substrates. Experiments 
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in which the nucleotides involved in tertiary interactions were altered, revealed that changes 
in these bases can be tolerated as long as the overall tertiary interactions are not disrupted. 
For example the 0 19- C56 tertiary Watson-Crick base pairs can be altered to C19- 0 56 
without affecting recognition by the phenylalnine AAS. Either of the single mutations, 
019~ Cor C56~ 0 leads to a five-fold drop in kcatiK.rn, indicating that the tertiary 
structure of the tRNA must be maintained but that neither 0 19 or C56 is recognized directly. 
When OrC72 is altered to either 0-U or A-U the kcatiK.rn drops four- and seven-fold, 
respectively (58a). It is not clear yet whether 0 1- C72 is important as a recognition element 
for the phenylalanine AAS, or as a structural feature. The results of this study led to the 
proposal that five nucleotides, all in single strand regions, are recognition elements for the 
phenylalanine AAS. They are the three anticodon bases, 0 34, A35, and A36, 0 20 in the 
D-loop, and A73 the fourth base from the 3' end (Figure 4). Several tests of the model 
were undertaken. First, the E. coli tRNAPhe, a rather poor substrate for the yeast 
phenylalnine AAS, contained all of the putative identity elements except the one at position 
20. Changing U20 to 0 brought kcat/Km to within a factor of two for that of yeast 
tRNAPhe. Identity swaps based on the conserved bases were also carried outl, changing 
yeast tRNAMet, tRNAAr&, and tRNATyr to good stubstrates for the phenylalnine AAS. It 
appears that each of the five bases contributes independently to the specificity. Thus, a 
tRNA containing four of the five recognition elements has a kcatiK.rn one order of 
magnitude lower than wild type, and a substrate with only three recognition elements has a 
kcat!Km which is two orders of magnitude lower. Some years ago Dudock and 
collaborators reported the mischarging of a number of tRNAs by the phenylalanine AAS 
(59). With knowledge of the recognition elements and thus relative contributions to 
specificity, Sampson and Uhlenbeck were able to reconcile that data nicely. Of the yeast 
tRNAs that have been sequenced none have more than three of the recognition elements so 
that the in vivo specificity can be explained if one also assumes a contribution to overall 
specificity due to competition with the cognate AAS. The five recognition elements are 
located far apart from one another in the tRNA tertiary structure so the phenylalanine AAS 
must contact the entire surface of the tRNA molecule. 
I Changes were incorporated elsewhere as well, either to facilitate the runoff transcription reaction, or to 
introduce tRNAPhe structural elements where they differed from the starting tRNA. 
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McClain and Foss have used the suppressor approach to investigate E. coli 
tRNAPhe identity. From their results it appears that U20 and A73 are implicated in tRNAPhe 
identity. In addition, small effects are observed in changing the anticodon stem base pairs 
27-43, and 28-42 (47). 
tRNAGln identity. 
It is pertinent to discuss what is known about the recognition of E. coli tRNAGln. In a 
short time we will know more about the interaction of this tRNA with its AAS than for any 
other system. At this point (October 1988) Steitz and Soli have generated tRNAGln..AAS 
co-crystals that refract to high resolution. Data has been collected and a map is being 
constructed Where do we expect the contacts will be made? 
First, as we have already mentioned, it is likely that the glutamine AAS recognizes 
the anticodon. The su+? allele of E. coli tRNA Trp , which inserts both glutamine and 
tryptophan in vivo, has a single change in the anticodon from CCA to CUA implicating the 
U in the middle position (45). In vitro, the su+? tRNA is a better substrate for the 
glutamine AAS by about six orders of magnitude (60). Changing the anticodon of E. coli 
tRNAMet(t) from CAU to CUA leads to misacylation by the glutamine AAS in vitro, at 
levels similar to that seen for su+? tRNA ( 44 ). The su+3 allele of E. coli tRNA Tyr does not 
mischarge in vivo but elevated levels of the glutamine AAS can lead to mischarging in vitro 
(61). 
We also anticipate that the glutamine AAS will interact with the 3' end of the tRNA. 
Mutants of su+3 tRNATyr with alterations at the 3' end result in recognition by the 
glutamine AAS. One of these mutants, A73~ G, is particularly effective (21-23). 
tRNA Gln has a G at position 73. Rogers and Soli have also described mutational changes 
of the tRNA Ser in the acceptor base pairs 1-72 and 2-73, which convert this tRNA to 
glutamine specificity in the DHFR assay (62). Note that these are also positions recognized 
by the serine AAS so competition between the two enzymes was decreased by making 
these changes. 
The Variable Pocket- A Potential Site in tRNA for AAS Recognition. 
In discussing the structure of yeast tRNAPhe , Klug pointed out that the cluster of 
nucleotides formed by the interaction of the D-loop and T-loop forms a patch that arches 
out from the molecular surface of the molecule (63). The nucleotides involved in this patch 
are 16, 17, 20, 59, and 60 (Figure 1 ). The patch is variable in that these nucleotides are 
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not conserved among different tRNAs, and there can be insertions or deletions in the 
D-loop which could potentially change the configuration of this pocket Klug explicitly 
suggested that this variable pocket may "form part of a recognition system for different 
tRNAs, perhaps for sorting into classes for synthetase discrimination." 
We have already seen that 0 20 in yeast tRNAPhe is a recognition element for the 
phenylalanine AAS (58). In an analysis of the six E. coli tRNAArg sequences, McClain 
observed a strong correlation of A20 with arginine identity. Consequently, a phenylalnine 
to arginine identity swap was attempted (64). The A20 was inserted into the phenylalanine 
D-loop causing U20 to become U20.1. This suppressor was not active. However, with the 
variable pocket model in mind, residues 16, 17, and 59 were altered in an attempt to create 
the variable pocket characteristic oftRNAArgACG-1· This suppressor inserts 75% arginine, 
5% lysine and 6% tyrosine. It is a significantly better arginine suppressor than one 
constructed simply by changing the anticodon of tRNAArgACG-1 to CUA, which inserts 
37% Arg and 55% lysine. Insertion of A20 and A59 alone had virtually the same effect. 
Taken together with the tRNAPhe results, this fmding certainly highlights residue 20 as an 
important synthetase recognition element. Given the exposed configuration of the variable 
pocket, other synthetases may well use different residues in this group as recognition 
elements. 
tRNA Specificity Defined by Nucleotide Modification. 
In general, tRNA modifications do not play a large role in tRNA identity. That this is so is 
most clearly demonstrated by the near normal substrate activity of unmodified transcripts. 
Indeed, even a tDNAPhe can be specifically aminoacylated (65). There is, however, a very 
interesting case in which a tRNA modification plays a crucial role not only in AAS 
recognition but in codon recognition as well. E. coli tRNAlle2 recognizes the codon AU A. 
It was therefore a surprise when it was discovered that the anticodon in the DNA sequence 
of the tRNAlle2 gene is CAT (66), the anticodon for methionine. The same sequence was 
found in the bacteriophage T4 tRNAile gene (67, 68), and in a spinach chloroplast tRNAlle 
gene (69). Recall that C34 in tRNAMet is a crucial recognition element. Thus, we have the 
dilemma that this tRNAlle should not only miscode, but it should also mischarge. The 
dilemma was resolved by the discovery that the C in tRNAlle2 is modified to lysidine 
(Figure 5). This alteration affects recognition by the synthetase; the unmodified tRNA is 
recognized by the methionine AAS and the modified tRNA by the isoleucine AAS (66). 
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Lysidine also changes the ccx:ling capacity of the tRNA so that it recognizes AVA and not 
AUG. Why is this bizarre route taken, rather than simply making that anticodon UAU? 
Muramatsu et al, suggest that the evolution of the lysidine mechanism may have allowed a 
change in the genetic code converting AUA from methionine to isoleucine specificity. Once 
the mechanism was fixed it was retained except in some mitochondria where AUA has 
reverted to methionine specificity. Muramatsu et al, suggest that this was due to the loss of 
the lysidine biosynthetic mechanism (66). 
CONCLUSION 
Much progress has been made recently with the application of two powerful methods to the 
study of tRNA identity. The in vitro approach assesses the contribution of specific 
nucleotides to tRNA identity by examining the aminoacylation kinetics of specifically 
altered tRNAs, providing a very clear picture of recognition elements for a given tRNA. 
Adding to this approach, determination of the in vivo specificity of altered tRNAs provides 
clues into the physiological relevance of specific nucleotides, i.e., what effect they have 
upon the competition between all 20 AAS. The experiments reviewed here have revealed 
the following: a) tRNA identity is defined by a relatively small number of elements, and b) 
the anticodon appears to be an important identity element for a majority of tRNAs. 
Identity elements may vary in the extent of their evolutionary conservation. For 
example the G3-U70 base pair so important for alanine identity is present in virtually every 
tRNAAla sequenced to date, over a wide phylogenetic spectrum. The same appears to hold 
true for the A20 found to be involved in arginine identity. The determinants of serine tRNA 
identity, however, are conserved only in bacterial genes. 
There are likely to be classes of tRNAs in regards to AAS recognition. On the 
simplest level, tRNAs can be classified according to the effect that an alteration in the 
anticodon has upon AAS recognition. Cognate recognition is either a) normal, or b) 
diminished/abolished. Within these subsets further divisions can be made. For example, 
both E. coli tRNAMet(m) and yeast tRNAPhe fall into the latter class. Yet for tRNAMet(m) 
the anticodon appears to be the sole identity element, while for yeast tRNAPhe two other 
nucleotides are important for complete phenylalanine acceptance. Similarly, E. coli 
tRNASer and tRNAAlafall into class one, i.e., the anticodon does not appear to play a role 
in cognate AAS recognition. While eight identity elements have been identified for 
tRNASer, a single basepair is primarily responsible for tRNAAla identity. 
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The phenomena oflysine and glutamine mischarging remain a mystery. The 
composition of the anticodon must in large part direct mischarging by these two AASs 
(e.g. aU at position 35 is a recurring theme in glutamine misacylation), but, as they do not 
misacylate universally, there must be identity determinants or deterrents outside of the 
anticodon that dictate which tRNAs can be readily misacylated. Both of these AASs may 
have rather loose specificity, and, subsequently, behave as "default" AAS for tRNAs that 
are not well charged by their cognate AAS. Sorting out identity determinants from 
deterrents will no doubt prove to be a difficult task; however, a systematic application of 
both the in vitro and in vivo approaches will go a long way towards solving the problem. 
Recent progress in the crystallography of tRNA-AAS complexes (8, 9) promises to 
give insight into the interaction between the two molecules, and will undoubtedly suggest 
new pathways to take in the study of the recognition problem. 
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Table 2. Amber suppressor tRNA genes in E. coli*. 








*The specificity of these tRNAs is not indicated. 


















































Leu (su+6;also synthetic Leu5) 











Table 4. Conversion to tRNAAla identity. 











(C3-G7o)-+ (G-U) . '
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tRNA identity 








Table 5. Aminoacylation kinetics ofwildtype and mutant tRNAPhe transcripts. 
tRNA 
yeast Phe 
E. coli Phe 
E. coli Phe 
yeast Met~ Phe 
yeast Arg~ Phe 
yeast Tyr ~ Phe 
*Represents an insertion 





A20--+G; C:M--+G; U36--+A; 
(G49-<:6s)--+(<:-G); As9--+U; 
<:2o--+G; U34--+G; <:35--+A; U36--+A; 
<:59--+U; <:73--+A;U--+17 * 
(U2o•U20-l•U2o-2)--+G; A13--+<:; 
A22--+G; (<:12-023)--+ (U-A); 












Figure 1. Secondary and tertiary structure of tRNA. In the cloverleaf structure (left) 
invariant nucleotides that are involved in stabilizing tertiary interactions are indicated; the 
lines indicate tertiary interactions between bases. Dots indicate base pairing. (Right) The 
L-model for tRNA tertiary structure. (4, 5) 
Figure 2. Cloverleaf secondary structure of tRNAAla. The G-U basepair at position 3-70, 
along with bases 20 and 60 (indicated by open circles) were predicted to be important 
alanine identity elements by statistical analysis (46). 
Figure 3a. Composite E. coli tRNASe:r. Bases highly conserved in serine tRNAs and not 
found in tRNALeuscuA are indicated. 
Figure 3b. Mutations introduced into tRNALeuscuA to effect the conversion from leucine to 
serine identity result in the mutant tRNALeu-+Ser. 
Figure 3c. The minimum number of nucleotides required to effect the leucine to serine 
conversion (25; Normanly & Abelson, unpublished). 
Figure 4. Nucleotides postulated to be important for yeast tRNAPhe identity (58). 
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ABSTRACT 
A leucine transfer RNA has been transformed into a serine transfer RNA by changing 12 
nucleotides. This result indicates that a limited set of residues determine tRNA identity. 
INTRODUCTION 
The rules for specificity in protein synthesis are to be found in the specific interactions 
between transfer RNA molecules and aminoacyl tRNA synthetases (AAS) (1). There 
exists a single AAS for each of the 20 amino acids, but because of the degeneracy of the 
genetic code and the limited range of allowed codon-anticoOOQ interactions (2), there are 
generally multiple tRNAs specifying each amino acid. The accurate transfer of information 
from messenger RNA to protein therefore relies on each AAS recognizing and acylating its 
cognate set of tRNAs while failing to acylate all others. All tRNAs so far sequenced (and 
the number is greater than 300) (3), can be folded into the familiar cloverleaf structure (4) 
and share a set of absolutely conserved nucletotides. The X-ray crystal structures of 
several tRNAs (5-8) show that these constant nucleotides are involved in stabilizing the 
tertiary structure of the tRNA molecule, therefore, by extrapolation, the tertiary structures 
in the cell are very similar. In some way, within the variations allowed by this framework, 
there exists a set of distinguishing features that constitute amino-acid specificity, that is, the 
identity of each tRNA. 
By contrast, aminoacyl tRNA synthetases are quite variable in structure; they range in 
size from 300 to 1,000 amino-acid residues and are found in various quaternary forms (9). 
Despite the variability of these enzymes, a unifying model has been proposed for the 
interaction between the tRNA molecules and AAS. Summarizing diverse chemical and 
physical studies involving several cognate complexes (10) (see also refs 9, 11, 12), Rich 
and Schimmel proposed that all AAS interact with tRNA along the inside diagonal of the L 
structure (5,6); the regions of contact inferred from these studies extend from the acceptor 
stem through the D stem to the anticodon loop. While the range of AAS contacts may be 
similar for all tRNA substrates, the rules for recognition lie in the detailed interactions and 
these must, of course, be idiosyncratic. For example, while the anticodon is clearly an 
important recognition element for the Escherichia coli tRNAfMet synthetase (13-15), this 
seems less likely to be the case for the serine and leucine synthetases because there are six 
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codons specifying each of their respective amino acids, requiring a set of isoacceptor 
tRNAs with different anticodons. 
A genetic approach to understanding AAS-tRNA recognition was taken over 15 years 
ago (16-19). In those experiments, a genetic selection was devised to isolate mutant 
tRNAs having altered specificity. In the initial experiments, the E. coli amber suppressor 
gene supF was used. This suppressor is a mutant allele of one of three tRNA Tyr genes in 
E. coli and can recognize the amber codon UAG because it has an altered anticodon, CUA 
(20) (for a review of nonsense suppression, see ref. 21). Among the amber mutants in 
bacterial and phage genes, there are some that can be suppressed by supD (serine) and 
supE (glutamine) but not by supF. Selection of supF mutants that could suppress this class 
of amber resulted in tRNA Tyr alleles with altered specificity. The mutations occurred in the 
first and second base pairs of the acceptor stem and in the fourth nucleotide from the 3' end 
of the tRNA ( 16,17,22-25). In all cases, the amino acid inserted by the mutant tRNAs was 
glutamine. This interesting result was somewhat obscured later by the fmding that amber 
suppressor alleles of the tRNA Trp gene also insert glutamine (26). One interpretation of 
these results is that the glutamine synthetase is indiscriminate and charges substrates that 
are not recognized by other synthetases. Other alterations in tRNA Tyr specificity were 
never observed, perhaps because too many changes are required. The approach remains an 
attractive one, however, because the alteration of identity with retention of tRNA function, 
by definition, reveals elements that determine specificity. 
The advances in oligonucleotide synthesis allowing rapid gene synthesis (27) have 
prompted a return to the genetic approach to studying AAS-tRNA interaction. If multiple 
changes are required to alter the specificity of a tRNA, they cannot be selected but they can 
be constructed. This is the approach we have taken here. 
METHODS 
Strains, Media, and Enzyme Assays. JMlOlis (F' traD36, proAB, 
lacNZml51t1(iac proB) supE thi). XAC-A16 is (F'laclam-Z!argEam, nalA, rif, t1(lac proB) 
metB, ara). The strains carrying supD, supE, supF, and supP are isogenic; (lac, proB, 
metB, argEam, rif, nalA, ara). MC1061/9100.1 is F'(lacN'2YA tn5/ lac, galU, galK, rpl 
t1(ara ABIOC-leu7679)hsr-hsm+). L broth was made from lOg!l Bactotryptone, 5g!l yeast 
extract, 8g!l NaCl. L plates contained 15g!l Bacto agar as well. 13-lactamase activity was 
36 
assayed as described by Dalbadie-McFarland eta/. (51) using ampicillin as a substrate. 
~-galactosidase activity was assayed as described by Miller (44). 
Gene Synthesis. Deoxyoligonucleotides were synthesized on an Applied Biosystems 
380A DNA synthesizer. Three to five A260 units of oligonucleotide were electrophoresed 
through a 20% acrylamidenM urea gel, visualized by ultraviolet shadowing, excised and 
eluted in 0.3M NaCl, lOmM Tris-Hel pH 7.4, lmM EDTA, 1% phenol at 37oe 
overnight. The DNA was precipitated with 100% ethanol, washed with 70% ethanol, dried 
and resuspended in dH20. Phosphorylations were carried out on 2ug of each 
oligonucleotide in 70mM Tris-Hel pH 7.6, lOmM MgCI2, 5mM dithiothreitol (DTT), 
lOOuM ATP, lOOuei 32P-ATP, with four units of polynucleotide kinase for 1 hat 37oe, 
followed by phenoVchloroform extraction and ethanol precipitation. 80 pmol of each 
phosphorylated oligonucleotide were incubated together in lOOmM Nael at sooe for 5 
min, then allowed to cool to room temperature over a period of 3 hr. The mixture was made 
50mM in Nael and combined with digested vector in a 10:1 insert to vector (mass) ratio. 
The vector in this case was M13mp8 containing a synthetic rrnC terminator (40) inserted 
into the Pst I-Hind ill sites. Use of this transcription terminator was suggested by the 
work of Y arus et a/.(60). Ligation was carried out in 50mM Tris-Hel, pH 7 .6, lOmM 
Mgel2, 20mM DTT, lmM A TP, 50ug/ml bovine serum albumin with 1 unit of T4 DNA 
ligase at 15oe for 12 hr. The ligation mixture was used to transform competent JM101. 
Single-stranded DNA from the resulting plaques was immobilized on nitrocellulose filters 
(61) and screened for the presence of inserts by first prehybridizing in lOx Denhardt's 
reagent (62), 0.2% SDS, 6x SSe (63), lmM EDTA for 2 hat 65oe, then hybridizing with 
4x J05 eerenkov c.p.m./rnl of one of the internal oligonucleotides in 5x DEnhardt's 
reagent, 6x SSe at sooe for 12 hr. The filters were washed in 6x SSe at room 
temperature for 5 min, then at sooe for 5 min and autoradiographed. Single-stranded 
DNA was prepared from positive candidates and sequenced according to the method of 
Sanger eta!. (64). 
Plasmid Construction. To construct plasmid pBR322-~am, the Eco RI-Pst I fragment 
of pBR322 was subcloned into M13mp8. Oligonucleotide-directed mutagenesis (65) of the 
~-lactamase gene was achieved using the 19-mer 5'TAAAAGTCTAeATCATTGG3'. After 
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verification of the mutant sequence, the Eco RI-Pst I fragment was transferred back into 
pBR322, yielding plasmid pBR322-pam. Pvu II fragments containing the synthetically 
constructed tRNALeuUAG or tRNALeu~serUAG gene together with the M13mp8-derived lac 
promoter and rrnC terminator were subcloned into the Pvu II site of pBR322-bam to yield 
pBR322-pam:tRNALeuUAG and pBR322-pam:tRNALeu~SerUAG. respectively. 
To construct plasmid pDA3-12, the 19-mer 5'ACGTAAAGCITAAACCGTC3' was 
used to create a Hind ill site in between the ribosome binding site and Pribnow box of the 
E. colifol gene (C. R. Morris, unpublished results) encoded by a 1 kilobase fragment 
contained in M13mp8 (66). This was done to facilitate subcloning of the gene into a tac 
expression vector. Subsequently, the 23-mer 5'GATAACGCGATTCfACGCfAACG3' 
was used for oligonucleotide-directed mutagenesis of the fol gene. The 247 -base pair (bp) 
Eco RI-Hind ill fragment of ptac12H (53) containing the tac promoter was ligated into the 
Eco RI-Hind III site ofpBR322 to create pTAClO. Subsequently, the DHFR amber, 
encoded by a 1,057-bp Hind ill fragment, was subcloned into the Hind ill site of 
pTAC10, yielding pDA3-12. The 392-bp Pvu II fragment from pBR322-pam:tRNALenuAa 
or pBR322-pam:tRNALeu~serUAG containing the lac promoter, synthetic tRNA gene and 
rrnC-derived terminator, was subcloned into the Pvu ll site ofpDA3-12 to yield 
pDA3-12:Leu or pDA3-12:Leu~Ser. 
DHFR Purification. Two liters ofMC1061/9100.1 carrying pTAClOl (the same 
construct as pDA3-12, except that thefol gene is wild type) in L broth were incubated at 
37oc with aeration to an A600 of 0.4-0.6, isopropyl thiogalactoside was added to 1 mM 
and the culture was incubated as before for an additional 4 hr. Cells were harvested and 
lysed (67) and the crude lysate was extracted with ammonium sulphate (68). The 90% 
ammonium sulphate-saturated insoluble fraction was brought to a protein concentration of 
20 mg/ml and dialysed with 3 ml of methotrexate-Sepharose (69) overnight. The resin was 
batch-washed and DHFR eluted with folic acid (69). To remove nucleic acid and folate, 
peak fractions were dialized against 50mM potassium phosphate pH 8.0, lmM DTT and 
applied to a DEAE-Sephacel column (lml per mg protein) equilibrated in the same buffer. 
DHFR was eluted in a linear gradient of 0-0.4M KCl, dialized against water and 
lyophilized. Mutant DHFR was purified in a similar manner but on a larger scale (121 for 
the tRNALeu~SerUAG substituted mutant) and the peak fractions from the DEAE column 
were passed through methotrexate affinity and DEAE columns a second time. Protein 
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sequence analysis was carried out on an Applied Biosystems Mcxlel470A gas-phase 
protein sequenator (58) by the USC Microchemical Core Laboratory. 
RATIONALE 
To defme the specific interaction between E. coli serine-specific tRNAs and their cognate 
AAS, we set out to transform a leucine-specific amber suppressor tRNA into an amber 
suppressor tRNA recognized exclusively by the serine AAS. We assume that there exists a 
limited set of changes one could make to a leucine tRNA that would entirely block its 
recognition by the leucine AAS and allow recognition solely by the serine AAS. The 
choice of this particular transformation was in part dictated by the fact that serine and 
leucine amber suppressor alleles exist in E. coli, and because all serine and leucine tRNAs 
fall into the type II structure class. Type II tRNAs have large extra loops in a stem-loop 
configuration and therefore lack the triple-base tertiary interactions, which are found in type 
I tRNAs (28). In addition, it is possible that the extra loop is a distinct structural feature 
recognized by the AAS for type II tRNAs, although this notion has not been addressed 
experimentally. 
Six different tRNASer isoacceptors recognized by the E. coli serine AAS have been 
sequenced (five E. coli tRNASer species and a T4 tRNASer; refs 29-34). Comparison of 
these sequences provides the information necessary to design the transformation. Such an 
approach was used previously to delineate sequences important in the recognition of 
tRNAPhe by the yeast phenylalanine AAS (9,35). Inspection of the serine tRNA sequences 
reveals 35 positions in which a nucleotide is absolutely conserved (Figure 1). It is likely 
that the specific residues that are necessary and sufficient for recognition of the set of 
tRNA Ser molecules by serine AAS are limited to these 35 nucleotides. Of these, 14 occur 
in all tRNAs (the constant nucleotides) and an additional seven are present in tRNALeu5. 
The remaining 14, detailed in Figure 2a, are concentrated in the acceptor stem and D arm, 
together with one each in the T'rC loop, extra arm, and anticodon loop, and two 
comprising a base pair in the anticcxlon stem. 
Figure 2b shows the proposed changes for the leucine to serine transformation, the 
justifications for which are as follows. We chose to focus only on the acceptor stem and D 
stem and loop as these domains have been shown to be in contact with the synthetase in all 
cases studied. In this initial exercise, we have ignored the T'rC stem-loop, the extra arm 
and the anticodon stem and loop. Although the anticcxlon has been strongly implicated in 
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some tRNA-AAS interactions (13-15,26,36,37), the existence of at least six isoaccepting 
species of serine tRNA, recognizing six different codons, and the existence of a serine 
tRNA suppressor allele, argues against a crucial role for the anticodon region in the case of 
serine tRNA recognition. Accordingly, the conserved tRNASer_specific bases at positions 
32 in the anticodon loop and the base pair 27-43 in the anticodon stem were not 
incorporated into the tRNALeu5 framework. We have thus superimposed the conserved 
serine nucleotides at positions 2, 71, 72 and 73 in the acceptor stem as well as positions 
20-1, and 21 in the D loop, and base pair 11-24 in the D stem. 
Looking at probable tertiary interactions in the leucine and serine tRNAs, there are 
five base-pair interactions common to both type I and ll tRNAs that appear to be 
responsible for stabilization of the tertiary structure (5,6,28); four of these, G18-U55, 
G19-C56, U54-A58 and U8-A14, involve constant nucleotides, and are therefore not directly 
affected by the alterations we propose. The fifth, a transtertiary base pair between residues 
15 and 48, is G15-C48 in all serine tRNAs. As this tertiary interaction is supplied in 
tRNALeu5 (albeit by an A-U pair), we elected not to alter bases 15 and 48. A difference in 
primary structure between tRNASer and tRNALeu which could account for a subtle 
difference in tertiary structure between the two sets of tRNAs, lies in the position of the 
constant nucleotides G18 and G19 in the D loop. Note in Figure 1 how the positions of 
G18 and G19 in tRNASer are offset by one nucleotide in comparison with G18 and G19 in 
tRNALeus. The question at this point becomes whether or not to maintain rigorously the 
leucine tRNA structure, and merely superimpose the predicted serine determinants on the 
leucine scaffold, or to alter the nature of the tertiary interactions to resemble those of a 
serine tRNA. As the position of 0 18 and 0 19 is a highly conserved feature of the serine 
tRNAs, we felt it may well be important for serine AAS recognition, especially in view of 
its location within the structure. Through an insertion and a deletion in the D loop of 
tRNALeus, these bases are kept in the same position relative to the D stem that is seen in all 
six tRNASer sequences. 
Finally, the 0-C to A-U change in the third base pair of the acceptor stem was not 
dictated by absolute conservation of that sequence among serine tRNAs but was suggested 
by a statistical study of E. coli tRNA sequences (W. H. McClain and H. B. Nicholas, 
personal communication) in which it was found that an A-U or U-A base pair at that 
position is significantly correlated with all tRNASer sequences and is anti-correlated with 
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other tRNA sequences. The rest of the proposed changes are compatible with the 
significant serine-specific residues detected in McClain's study. 
To effect this transformation of a leucine amber suppressor tRNA, we first 
synthesized a leucine amber suppressor tRNA gene and then altered it at the residues 
indicated in Figure 2b. 
SYNTHESIS OF tRNALEU SUPPRESSOR GENE 
The sequence of the starting leucine amber suppressor gene was based on the sequence of 
E. coli tRNALeus with substitution of the anticodon to CT A. tRNALeus recognizes the 
codon UUA and has a different sequence from the leucine amber suppressor supP, as 
became apparent from studies published after the present work was started (38,39). The 
synthetic gene, tRNALelluAo, is comprised of six overlapping oligonucleotides, which were 
annealed and ligated into the M13 vector mp8 containing a synthetic transcription terminator 
(see Figure 3). In this construction, transcription of the tRNA gene is directed from the lac 
promoter and is expected to terminate within the sequence derived from the ribosomal RNA 
cistron rrnC ( 40). No provision was made for the inclusion of natural 5' and 3' flanking 
sequences, as the nucleases that process tRNA precursor transcripts are not 
sequence-specific; instead, they recognize conserved features of secondary and tertiary 
structure common to all tRNAs (41). It was therefore anticipated that a tRNA could be 
correctly processed from any flanking sequence context. 
To ascertain that the synthetic gene produced a functional tRNA, we assayed for 
suppression of an amber mutation in an E. coli strain carrying the tRNALeuUAG gene. The 
amber mutation resides in the N-terminallacl portion of a lacl-Z fusion gene (42). Activity 
of the lacZ gene product, (>-galactosidase, is unaffected by the lacl portion of the fusion, 
hence quantitation of ~-galactosidase activity gives a measure of the extent of suppression 
of the amber mutation. The tRNALeuUAG gene, together with its terminator, was subcloned 
into plasmid pEMBL8+ (ref. 43) and transformed into the lacl-Z amber strain XAC-A16. 
Suppression efficiency was determined directly by assaying for (>-galactosidase activity 
(44). When tested in this way, the tRNALeuUAG suppressor is 60% efficient, producing 
substantial levels of (>-galactosidase. 
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SYNTHESIS OF tRNALEU~SERUAG GENE 
For construction of the tRNALeu~serUAG gene, four additional oligonucleotides were 
synthesized and combined with two of the tRNALeuUAG gene chains as shown in Figure 3. 
This gene was then transferred to the pEMBL8+ vector and its activity assayed using the 
lacl-Z amber strain. The tRNALeu~serUAG gene is active but produces a much weaker 
suppressor than its parent, exhibiting a 0.5-1% efficiency of suppression. By contrast, the 
supD suppressor (serine) is 35% efficient. 
To determine the specificity of this suppressor, two approaches were taken. The first 
approach uses an amber mutant in the ~lactamase gene that is functionally suppressed only 
by a serine suppressor. This approach allows the selection of serine amber suppressors. If 
our design of a suppressor with serine identity had been wrong by one or two nucleotides, 
the serine-specific amber could have been used to select an active serine suppressor by 
spontaneous or induced mutation. Alternatively, this mutant could be used to select 
stronger variants of a weak serine suppressor. In the second approach the 
tRNALeu~SerUAG suppressor was used to suppress an amber mutation near the beginning of 
the E. coli dihydrofolate reductase genefol, and subsequently the suppressed protein was 
sequenced. 
SERINE-REQUIRING AMBER MUTATION 
The active site of ~lactamase contains an essential serine residue (45,46), which 
participates in the cleavage of the ~lactam ring of ampicillin and thereby confers antibiotic 
resistance to cells harbouring the f3-lactamase gene amp. By oligonucleotide mutagenesis 
we converted the AGC serine codon at residue 68 (residue 70 according to Ambler's 
nomenclature, ref. 47) of pBR322 amp gene to TAG (Figure 4a). Figure 4b shows that 
this mutation can be suppressed in an E. coli supD strain (supD inserts serine) but not by 
supE (glutamine), supF (tyrosine) or supP (leucine). The only other amino acids, which 
might be expected to substitute for serine at this position based on some knowledge of the 
reaction mechanism (48), are cysteine and threonine. These substitutions have been made 
( 46,49-51) and in the case of cysteine resulted in an enzyme with 1/30 of wild-type 
activity. In the case of threonine, the enzyme was inactive (51). The active-site amber 
mutation therefore meets our requirements as apparently it can be functionally suppressed 
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only by a serine-inserting suppressor. 
The synthetic suppressor genes tRNALeuUAG or tRNALeu~SerUAG, together with the 
lac promoter and rrnC terminator, were ligated into the Pvull site of pBR322-~Wu. Each 
plasmid was introduced into E. coli and the transformants were tested for growth on 
tetracycline and ampicillin. Only the tRNALeu~SerUAG suppressor allowed growth on 
ampicillin (Figure 4c). Futhermore, the cells containing tRNALeu~seruAo-suppressed 
!3-lactamase are fully viable in the presence of the drug at 80 J,Jg mi-L We conclude that 
tRNALeu~serUAG is a functional tRNA that inserts serine. This experiment cannot, 
however, exclude the possibility that the tRNA inserts other amino acids also. The only 
way to determine the specificity of suppression is to sequence through the site of the amber 
mutation in a suppressed protein. 
tRNALEU-+SERuAG SPECIFICITY 
To determine the specificity of the tRNALeu~serUAG suppressor, we needed to use it for 
suppression of an amber mutation close to the beginning of a gene whose product is 
relatively small, easy to purify, and present at high concentration. The E. coli 
dihydrofolate reductase (DHFR) gene,fo/, proved an attractive candidate. We linked the 
fol gene, the sequence of which is known (52), to the tac promoter (53) in the expression 
vector pTAClO (Figure 5). The 159-amino acid DHFR protein represents approximately 
10% of the total protein in fully induced strains of E. coli harbouring this plasmid, and is 
easily purified by methotrexate affinity chromatography. An amber mutation at a site near 
the N-terminus would allow sequence determination of the suppressed DHFR by Edman 
degradation (54) of the intact protein. Residues 2-8 constitute a strand of a !3-pleated sheet 
and are part of the NADP binding site. We chose position 10, a valine residue found in a 
loop on the surface of the protein, because this residue is not phylogenetically conserved 
and X-ray crystallographic data reveal that it is well removed from the active site (55-57). 
Substitution of any residue at this site should not affect the purification of DHFR on a 
methotrexate affinity column. Another point to consider is that the efficiency of amber 
suppression and therefore the yield of suppressed protein is dependent on the context of the 
amber codon. UAG codons followed by A residue are usually better suppressed than those 
followed by a G (42). Consequently, by oligonucleotide-directed mutagenesis, we altered 
the DHFR sequence GTA-GAT of codons 10 and 11 to TAG-AAT, changing the protein 
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sequence from Val-Asp to amber-Asn. This alteredfol gene, together with its tac 
promoter, was transferred to plasmids carrying either the tRNALeuUAG or tRNALeu--tSerUAG 
genes (Figure 5a). Figure 5b documents the purification of DHFR from a strain 
harlx>uring the wild-type gene under control of the tac promoter (pTAC101). 
Dihydrofolate reductase was purified from four strains: one carrying pTAC101, 
another a supD strain harbouring the DHFR amber mutant in the tac expression vector 
(pDA3-12), and the third and fourth carrying pDA3-12:Leu and pDA3-12:Leu~er, 
respectively. Each purified protein was sequenced by Edman degradation using an 
automatic gas-phase sequencer (58). In interpreting these results (Figure 6), it should be 
considered that the chromosomal copy of the fol gene is present in these strains, leading to 
fractional yield (usually small) of Val-Asp at positions 10 and 11. This sequence is very 
clearly seen when wild-type DHFR is sequenced but when the DHFR amber is suppressed 
by the tRNALeuuAG suppressor, the sequence is unambiguously Leu-Asn at positions 10 
and 11. Overproduction of the plasmid-encoded DHFR is probably greater than 100-fold 
and the tRNAl..euuAG suppressor is efficient. When the DHFR amber is suppressed by 
supD, serine is clearly present in position 10, demonstrating that the well known problems 
in detecting serine in Edman degradation have been overcome. Here, valine is clearly not 
detected at position 10 but there is some aspartate at position 11; we believe this results 
from deamidation of asparagine. 
When the DHFR amber is suppressed by the tRNALeu--tSerUAG suppressor, there is a 
good yield of serine at position 10, but also a detectable (12-15%) amount of valine. The 
presence of valine is due to the fact that the tRNALeu--tSerUAG suppressor is weak, giving 
rise to a lower ratio of suppressed protein to wild-type protein. There is also a small 
amount ( 10%) of leucine at position 1 0; this is probably due to carry-over of the leucine 
from postion 8, but the experimental method used cannot exclude the possibility that the 
tRNAl...eu--tSerUAG suppressor inserts small amounts of leucine or valine. We could detect 
no other amino acid at position 10, and conclude that we have changed a strong leucine 
suppressor to a weak serine suppressor. 
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DISCUSSION 
Comparison of the sequences of six serine tRNAs, which are substrates for the E. coli 
serine AAS reveals several conserved nucleotides. Here we altered an amber suppressor 
allele of tRNALeus at 12 positions to yield a tRNA sequence containing a subset of these 
conserved serine residues-those located in the acceptor stem and in the D stem and loop. 
The resultant molecule is a weak suppressor, which inserts serine in response to amber 
nonsense codons. The specific acquisition of tRNASe:r identity was established by a highly 
discriminatory functional assay, while the loss of tRNALeu identity in exchange for unique 
acquisition of tRNA Ser identity was established by protein sequencing. Our study 
demonstrates that a limited number of nucleotides by virtue of their nature and position on a 
tRNA scaffold, are sufficient to dictate cognate synthetase recognition. It is noteworthy 
that this result was achieved with only primary and secondary structure information about 
the two tRNAs and no knowledge of the AAS structures. 
A number of questions remain of course. We have converted a strong suppressor 
into a weak suppressor. This reduction in efficiency may be the result of a weak interaction 
between the suppressor tRNA and serine AAS. Alternatively, it may reflect a perturbation 
in the general tRNA structure resulting in poorer competition with the release factors. 
THere are two possible routes to producing a better suppressor with serine specificity. 
First, we can further alter the sequence by including those changes in the anticodon stem 
and TPC loop that were conserved in all serine tRNAs, but which we chose to ignore. 
Our predictions about the importance of specific tertiary interactions in AAS recognition 
also warrant a more systematic investigation. Perhaps a better method, however, is to 
mutagenize the gene and select stronger serine suppressors by requiring suppression of the 
~-lactamase active-site amber in the presence of increasingly higher levels of ampicillin. 
When a strong serine suppressor is generated, the sequence of the tRNA will be 
determined. At that point, we can begin a systematic analysis of the identity switch to 
determine which changes were necessary. Eventually, the minimum set of changes 
required to transform tRNALeu to tRNASer can be determined. This information will then 
be used to effect a different transformation, for example, tRNATyr to tRNASer. It will 
clearly be necessary to gather supporting in vitro kinetic and thermodynamic data for the 
various tRNAs and AAS involved. This iterative method can lead to a more detailed 
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understanding of the essence of serine tRNA identity. 
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FIGURE LEGENDS 
Figure 1. Serine tRNAs recognized by E. coli serine AAS (29-34) compared with E. coli 
tRNALeu5 (ref. 59 and K. Jones B. Reid, personal communication). Boxed nucleotides 
indicated absolute conservation among the five tRNASer sequences. The conserved serine 
nucleotides that differ from tRNALeu5 have been underlined in the tRNALeu5 sequence. A 
fifth E. coli serine tRNA has been sequenced (not shown) and is identical to that of E. coli 
4, except for residue 20, which is a C (39). Ace. stem, acceptor stem. A. C., anticodon. 
Figure 2. a)Cloverleaf representation of conserved E. coli tRNASez- residues. The indicated 
nucleotides are those that are absolutely conserved in all six serine tRNAs and not found in 
tRNALeu5. b) tRNALeu5 with the changes proposed to confer tRNASerspecificity. The 
modified nucleotides are those present in tRNALeu5. Note that the changes in the D loop at 
positions 20-2 and 21 are equally well represented by insertion of an A between residues 
21 and 22. Thus there are actually 11 independent changes. 
Figure 3. The tRNALeuUAG gene was constructed from six oligonucleotides containing the 
tRNALeuUAG sequence flanked by Eco RI and Pst I restriction endonuclease cohesive ends 
at the immediate 5' and 3' ends of the gene respectively. Junctions between 
oligonucleotides are indicated. The four oligonucleotides containing the appropriate 
sequence alterations for construction of tRNALeu-+Sez-UAG exactly replace four of the 
tRNALeuUAG oligonucleotides, and are shown above and below the tRNALe~AG sequence. 
The sequence of the terminator, synthesized as two chains, is indicated. 
Figure 4a. Sequence of the serine-requiring amber mutation in the amp gene of pBR322, 
generated by oligonucleotide-directed mutagenesis. Pvu II fragments containing the 
synthetically constructed tRNALeuUAG or tRNALeu-+SerUAG gene together with the 
M13mp8-derived lac promoter and rrnC terminator were subcloned into the Pvu ll site of 
pBR322-~am to yield pBR322-~am:tRNALeuUAG and pBR322-~am:tRNALeu-+SerUAG. 
respectively. 
Figure 4b. Suppression of the serine-requiring amber mutation. Isogenic E. coli strains 
carrying the supD, supE, supF and supP alleles were transformed with pBR322-~am and 
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plated on L plates containing either 20ug/ml tetracycline or 80ug/ml ampicillin. 
Figure 4c. Suppression of serine-requiring amber mutation by tRNALeu-+SerUAG· 
XAC-A16 was transformed with either pBR322-~am:tRNALeuUAG or 
pBR322-~am:tRNALeu-+SerUAG and plated as in (b), except that IPTG was added to lmM. 
~-lactamase activity in the latter strain was 2% the level seen in a strain harbouring 
wild-type pBR322 and 5% the level seen when this mutation was suppressed by supD. 
Figure 5 a) Sequence of the fol amber. Asp 11 (GAT) was changed to Asn (AA T) to 
improve the context of the amber mutation. Pvu II fragments encoding either tRNALeuuAG 
or tRNALeu-+SerUAG along with the lac promoter and rrnC terminator were subcloned into 
the Pvu II site of plasmid pDA3-12 to yield plasmids pDA3-12:Leu and 
pDA3-12:Leu-+Ser, respectively. b) DHFR purification visualized by Coomassie blue 
staining of an SDS-polyacrylamide gel. Lane 1, crude extract; Lane 2, 90% ammonium 
sulphate-saturated insoluble fraction; Lane 3, flow through from methotrexate sepharose 
column; Lane 4, folic-acid eluate from methotrexate sepharose; Lane 5, peak protein 
fraction from DEAE sephacel column. 
Figure 6. Protein sequence analysis of wild-type DHFR (frrst column of graphs), 
DHFRam/Leu suppressor (second column), DHFRam/Ser suppressor (third column), and 
DHFRam/Leu-+Ser suppressor (fouth column). The picomolar yields of 
phenylthiohydantoin (PTII) derivatives of valine, aspartic acid, asparagine, leucine and 
serine are plotted against the residue number for wild-type DHFR, isolated from E. coli 
carrying pTAClOl, and mutant DHFR isolated from strains carrying pDA3-12:Leu, or 
pDA3-12:Leu-+Ser, as well as from a supD strain carrying pDA3-12. 
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Eight base changes are sufficient to convert a leucine-inserting tRNA 
into a serine-inserting tRNA 
60 
INTRODUCTION 
The identity of a tRNA is defined by the elements within the tRNA that are responsible for 
the correct aminoacylation of the tRNA by its cognate aminoacyl tRNA synthetase (AAS). 
The correct aminoacylation of a tRNA is the outcome of two types of interactions, 1) the 
positive interaction between a tRNA and its cognate AAS, and 2) the negative interaction 
between a tRNA and all 19 noncognate AASs. The determinants of these positive and 
negative interactions are in the nucleotides of any given tRNA. One method that has been 
used to determine which nucleotides comprise a tRNA's identity is referred to as an identity 
swap. In this approach, the identity of a tRNA is altered with the fewest changes, while 
retaining its complete biological function. Those changes responsible for redirection of 
AAS recognition constitute identity elements. 
In an effort to defme the identity elements of E. coli serine tRNA, we have developed 
a system to facilitate the identity swap approach. Amber suppressor tRNA genes containing 
the alterations predicted to redirect AAS recognition are assembled from oligonucleotides 
and inserted in cassette form into a plasmid, which supplies the inducible lac promoter and 
a transcription terminator (1). First, the biological function of the mutant tRNA is 
established by assaying the efficiency at which the tRNA can suppress a LacZ amber 
mutation. This mutation, in a non-essential portion of LacZ, can tolerate any amino acid. 
Second, we screen specifically for the insertion of serine using a mutant of the amp gene, 
which contains an amber mutation in the essential, active-site serine residue (2). Finally, 
the amino acid specificity of the supperssor is determined by sequencing the protein 
product of a suppressed amber mutant gene. For this purpose the E. coli dihydrofolate 
reductase (DHFR) gene,fol, with an amber mutation at codon ten is used. DHFR is easily 
purified by affmity chromatography on a methotrexate resin. X-ray crystallographic data 
(4, 5) reveals that residue ten of DHFR lies on the surface of the protein, well removed 
from the active site, and it appears that any amino acid is acceptable at this position. If 
more than one amino acid is inserted by the suppressor, they can be readily detected by this 
method. Protein sequence data acquired in this manner reveal the outcome of the 
competition among all 20 AAS in the cell for the suppressor. 
Previously, we reported the conversion of a leucine-inserting amber suppressor 
tRNA into a serine-inserting amber suppressor tRNA (1). Comparison of six E. coli 
serine-accepting tRNAs revealed 16 nucleotides, which were highly conserved among, or 
highly correlated with, serine tRNAs, yet not found in the leucine tRNA that we used as a 
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starting tRNA. Twelve of the 16 nucleotides were superimposed upon the amber 
suppressor allele oftRNALeu5, by constructing a tRNA gene from synthetic 
oligonucleotides that encoded the leucine tRNA with the twelve base changes that we 
wished to incorporate. The resultant tRNA, tRNALeu~serUAG was a weak suppressor (1% 
efficient as determined by ~-galactosidase assays) yet it insetted predominantly serine 
(Table 1). 
Here, we describe our efforts to determine the minimum number of base changes 
necessary to effect the leucine to serine conversion, and to increase the suppression 
efficiency of the tRNA. We speculated that not all of the 12 nucleotide changes were 
necessary for the conversion and may have been responsible for the low suppression 
efficiency of tRNALeu~serUAG· By reverting the mutations singly or in groups, we . . 
determined that a minimum of eight base changes were required to effect the leucine to 
serine conversion. They were basepair C11-G24 in the dihydrouridine (D) stem, base pairs 
GrC71, A3-U7o. and nucleotides Cn and G73, all in the acceptor stem. These eight 
nucleotides, when incorporated into a leucine tRNA, yield a tRNA that inserts exclusively 
serine with 40% suppression efficiency. 
METHODS 
Gene Construction. The tRNA genes were constructed from synthetic oligonucleotides 
(made by the Caltech Microchemical Facility), which were assembled as described 
previously (1), and cloned into the vector pJN10. pJN10 is derived from plasmids 
pBR322 (6) and pEMBL8+ (7). The Pvui-Pvuii fragment from pEMBL8+ containing a 
portion of the amp gene, the replication origin, and the poly linker, was ligated to the 
Pvui-Pvuii fragment of pBR322 that carries the tet gene. In pJN10, the amp gene lacks a 
Pst I site, and, additionally, contains an amber mutation at its active site serine. Prior to 
constructing pJNlO, the Eco RI site in pBR322 was removed by digesting pBR322 with 
Eco RI, filling in the "sticky ends" with Klenow and ligating. tRNA genes are ligated into 
the Eco RI-Pst I sites located in the polylinker region ofpJN10, which are flanked by the 
lac promoter and rrnC terminator, 5' and 3', respectively. Plasmid pJN10, into which a 
suppressor tRNA gene has been cloned, will be referred to as pJN10:sup. 
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Determination of suppression efficiency: Suppression efficiencies were 
detennined by assaying ~-galactosidase activity (7) in strain XAC-1 (F'laci373 LacZullBam 
proB+fil(lacproB)xlll nalA, rif, ara, argE~. which had been transformed with 
pJNlO:sup. 
Specificity assay: purification of DHFR: DHFR was isolated from XAC-1 
carrying pJNlO:sup and plasmid pDA YQ. pDA YQ encodes the gene conferring resistance 
to chloramphenicol as well as the gene encoding DHFR,fol, with an amber mutation at 
residue ten (Normanly and Abelson, unpublished). The fol gene is under the control of the 
tac promoter (8). Cells were cultured in L broth (lOg/1 bactotryptone, 10g/1 NaCl, 5g!l 
yeast extract) supplemented with 5ug/ml tetracycline and 30ug/ml chloramphenicol to an 
A600 of 0.4-0.8, at which time they were diluted fifty-fold into minimal M9 Glycerol 
medium (7), which had been supplemented with 5ug!ml tetracycline, 30ug/ml 
chloramphenicol, and lmM IPTG. The culture was incubated, shaking, at 370C for 12 to 
18 hr., and the cells harvested. DHFR was purified from the cells as described in (1). 
N-terminal sequence analysis of DHFR was canied out at either the USC Microchemical 
Core Laboratory or the Caltech Microchemical Facility. 
RESULTS 
Figure 1a shows the nucleotides that are highly conserved in serine-accepting tRNAs (or as 
in the case of basepair 3-70, highly correlated) and which are not found in tRNAleu5UAG· 
our starting tRNA. Figure 1 b shows the original leucine to serine conversion, 
tRNAleu~serUAG (1), with the 12 changes indicated. We first examined the contribution of 
the mutations in the D loop. In tRNAleu~serUAG· we had shifted the position of the 
conserved nucleotides G18 and G19, based upon the observation that the position of these 
nucleotides (relative to the D stem), which is highly conserved in serine tRNAs, differs 
from the position ofG18 and G19 in leucine tRNAs. We predicted that this structural 
feature may play a role in serine AAS recognition, and therefore, altered the leucine D loop 
to introduce a serine-like configuration (Figure 1b). In mutant LSM6 (Figure 2) the D loop 
has the original tRNAleu5 sequence and configuration, while the mutations in 
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the D stem and acceptor stem are retained. This suppressor inserted exclusively serine at 
high efficiency (Table 1). 
We next examined the contribution of the mutations in the D stem (basepair 11-24) by 
generating a mutant that contained mutations in the acceptor stem only, and none in the D 
loop or stem. This variant, LSM4 (Figure 3), while an efficient suppressor, inserted a 
mixture of amino acids: serine (16% ), glutamine (39%) and leucine (38% ). Clearly, 
basepair C11-024 plays a role in serine acceptance. In all serine tRNAs base pair 11-24 is a 
C-0 and in tRNALeu5UAG is aU-A. We wondered if aU-G basepair would be acceptable 
at this position, thereby pinpointing 0 24 as the identity element Mutant LSMll (Figure 4) 
contained a U-0 at position 11-24, along with the original mutations in the acceptor stem 
This variant suppressed the ~-lactamase amber sufficiently to enable growth in the presence 
of ampicillin; however, the specificity assay revealed that LSM11 inserts predominantly 
leucine (62%), glutamine (33%) and only 1% serine. From these data we established that 
alterations to the D loop were unnecessary, and from the standpoint of suppression 
efficiency, most likely deleterious. Base pair C11-024, however, plays a key role in serine 
AAS acceptance. 
We next set out to determine which of the original changes in the acceptor stem were 
actually necessary by reverting one base pair or nucleotide at a time, retaining the remainder 
of the acceptor stem changes as well as the essential C-0 pair at position 11-24. 
In mutant LSMlO, position 73 has been changed back to an A, while the other 
acceptor stem mutations, and the mutations at basepair 11-24 have been retained (Figure 5). 
This tRNA variant inserts exclusively leucine. In mutant LSM12 (Figure 6) basepair 2-71 
has the original leucine sequence, C-0, and in mutant LSM13 (Figure 7) position 72 has 
the leucine sequence U. Both of these mutants insert predominantly leucine and glutamine 
(Table 1). In mutant LSM9 (Figure 8) the A-U at 3-70 has been changed to the C-0 found 
in tRNALeu5UAG· This tRNA inserts predominantly leucine (72% ), some serine (20%) and 
glutamine (6%), indicating that A3-U70 is necessary for complete serine identity. The A-U 
pair at position 3-70 is not highly conserved in serine tRNAs, some have aU-A at this 
position. A mutant, LSM14, with aU-A at position 3-70, along with the other acceptor 
and D stem mutations (Figure 9) inserts predominantly leucine (65%) along with glutamine 
(19%) and serine (11 %). It would appear that aU-A pair at position 3-70 results in a loss 
of serine identity. This is odd considering that some serine tRNAs have a U3-A7o pair. It 
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is possible that an A3-U70 pair plays less a role in serine identity but rather acts as a 
deterrent to the leucine or glutamine AASs. 
From these reversion studies it is apparent that all of the original changes made in the 
acceptor stem were necessary to convert a leucine-accepting tRNA into a serine-accepting 
tRNA. Including basepair 11-24, the minimum number of changes to effect the leucine to 
serine conversion is eight, illustrated in Figure 2. This tRNA (LSM6) is also a very 
efficient suppressor, indicating biological function. 
It is possible that in this initial experiment, some of the serine identity elements would 
not have been discovered if, for example, they happened to be present in the tRNALeu5UAG 
that we used as a starting tRNA. To further define the elements of serine identity, we 
wished to convert another tRNA to serine acceptance. Therefore, we attempted to convert a 
tyrosine tRNA to a serine tRNA. We chose a tyrosine tRNA because in E. coli this species 
of tRNA, like the leucine and serine tRNAs, belongs to the type II class. Type II tRNAs 
are distinguished from type I tRNAs (in E. coli type I tRNAs constitute the remainder of 
tRNA species) primarily in the size of their extra loop, which is larger, 9 to 21 nucleotides, 
as opposed to 4 to 5 nucleotides for type I tRNAs (9). As the function of the extra arm is 
not understood, we elected to remain within the type II class for our identity swap 
experiments. 
Figure 10 shows the nucleotides highly conserved in serine tRNAs but not found in 
the su+3 allele of tRNATyr (10). The leucine to serine identity swap experiments revealed 
that alterations in the D loop were unnecessary for generating a serine accepting tRNA; 
furthermore, it was not necessary to make alterations in the anticodon stem of tRNALeu5UAG 
to obtain serine identity. We therefore chose to make only two changes to the tyrosine 
tRNA, those at postion 9 and 73. This mutant, Tyr~er1 (Figure 11), enabled growth in 
the presence of ampicillin, yet inserted predominantly glutamine (71% ), tyrosine (26%) and 
only 1% serine, as determined by the specificity assay (Table 1). While we may have 
introduced a serine determinant, we also either introduced a glutamine identity element or 
removed a deterrent. Also, Tyr-+Serl retained tyrosine identity elements. This result did 
not come as a complete suprise to us, as a tyrosine amber suppressor (su+3) with the same 
alteration at position 73 as in the Tyr~er1 mutant, inserts glutamine (11-13). We made 
two other attempts at a tyrosine to serine identity swap; Tyr~er2 (Figure 12) has 
alterations at all seven of the positions highly conserved in serine that are not found in 
tyrosine. Tyr~er3 (Figure 13) has changes at positions 9, 73, and basepair 3-70. Neither 
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mutant inserts more than 1% serine, both insert predominantly glutamine and some tyrosine 
(Table 1). 
DISCUSSION 
Previously, we reported the conversion of a leucine-inserting tRNA into a serine-inserting 
tRNA, brought about by making 12 base changes in the leucine tRNA (1). We have now 
determined which of those 12 changes were necessary, i.e., the minium number of 
changes required to effect the leucine to serine identity conversion. Only eight base 
changes are necessary, those at positions 11-24 in the D stem, 2-71, 3-70, 72, and 73 in 
the acceptor stem. 
In making the original tRNAl.eu-+SerUAG, we shifted the position of 0 18 and 0 19 in 
the leucine tRNA to conform to the configuration of a serine D loop. We found that not 
only was this alteration unnecessary for serine AAS recognition, it had a deleterious effect 
upon the suppression efficiency of the tRNA. We have also found that, while serine 
tRNAs may have either an A-U or U-A at position 3-70, in the leucine to serine identity 
conversion, an A3-U70 pair is essential, while a U3-A70 pair results in charging by the 
glutamine and leucine AASs. Possibly, the A3-U70 acts less as an identity element for 
serine AAS, but in the context of the tRNAl.eu-+SerUAG sequence, acts as a deterrent to the 
leucine and glutamine AASs. It would be interesting to see what effect an A3-U70 pair 
would have upon the identity of a serine tRNA which normally has aU-A at position 3-70. 
Identity swap experiments have been used to defme the identity elements for E. coli 
tRNAAla (14-16). A 0-U pair at position 3-70 is unique to alanine tRNAs, and all alanine 
tRNAs that have been sequenced to date have this 0 3-U70 pair. Superimposing this 
0 3-U70 pair onto an amber alleles of E. coli tRNACys or tRNALYs, results in complete 
alanine identity (14, 16). When the 0 3-U70 is superimposed upon a phenylalanine amber 
suppressor tRNA, the tRNA inserts predominantly alanine into amber codons, however it 
inserts some phenylalanine as well (14, 15). Yet when the 0 3-U70 pair is superimposed 
upon a glycine amber suppressor tRNA, there is no conversion to alanine identity (15). 
These experiments highlight one of the problems encountered when attempting to define 
tRNA identity, and help to explain our failure to effect a complete conversion from tyrosine 
to serine identity. Merely superimposing predicted identity elements onto a tRNA is not 
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sufficient to effect a complete conversion of identity. One has to contend with the positive 
or negative recognition elements for all other AAS, which also reside in the tRNA being 
studied. 
While we were able to introduce serine identity elements into the tyrosine tRNA 
sequence (all the mutants; Tyr~Ser1 Tyr~Ser2 and Tyr~Ser3 were able to adequately 
suppress the serine requiring amber mutation in the amp gene), tyrosine identity elements 
remain in the tRNA. Additionally, we either introduced glutamine identity elements or 
removed glutamine AAS deterrents. As stated above, the introduction of a G at position 
73 of a tyrosine amber suppressor (su+-3, the same allele used in our experiments) results 
in glutamine mischarging. Yet, in a leucine amber suppressor, an A to G change at 
position 73 does not result in glutamine mischarging. In fact, the phenomenon of 
glutamine mischargine is not new. A number of amber suppressor tRNAs are mischarged 
by the glutamine AAS. There must be a context effect; that is, there must be other glutamine 
determinants or a lack of glutamine deterrents present in those tRNAs that are mischarged 
by the glutamine AAS, while the opposite must be true for tRNAs that are not mischarged. 
Sequence comparison between tRNAs that are, or are not, mischarged by the glutamine 
AAS does not reveal any uniquely conserved nucleotides. 
In summary, identity swap experiments have proven instructive about the nature of 
serine tRNA identity, however, we will not be able to fully refme our model until we have 
a better understanding of the positive and negative identity elements of other tRNAs, 
glutamine tRNAs in particular. 
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Table 1. 
tRNAuAG Suppression Efficiency 













Tyr~Ser 1 6-8 
Tyr~Ser 2 35-44 
Tyr~Ser 3 21-23 
Growth on amp Specificity 
(given in % amino 
acid inserted at DHFRam1o) 
Leu (99) 
+ Ser (92) 
+ Ser (90),Leu(10) 
+ Ser (92) 
+ Leu (38),Gln (39),Ser (16) 
+ Leu (62),Gln (33),Ser ( <1) 
Leu (99) 
Leu (91),Gln (9) 
+ Leu (15), Gin (78),Ser (<1) 
+ Leu (72),Gln (6),Ser (20) 
+ Leu (65),Gln (19),Ser (11) 
Tyr (95) 
+ Gln (71),Tyr (26),Ser (1) 
+ Gln (71),Tyr (29),Ser(<1) 
+ Gln (82),Tyr (13), Ser (1) 
Values for percent amino acid inserted may not total100%, because background levels of 
less than 5% for any amino acid are not included with the exception of serine. While the 
values given for % serine inserted is below 5% in some cases, the ability to confer 
ampicillin resistance indicates that the mutant must be inserting some low level of serine. 
Estimates for% Gln inserted include Glu. amp; ampicillin 
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FIGURE LEGENDS 
Figure 1a. Composite of E. coli serine tRNAs. Nucleotides highly conserved in or 
correlated with serine tRNAs and not found in tRNAl.eu5UAG are indicated Adapted from 
(1). 
Figure 1 b. tRNA Leu5UAG with twelve base changes predicted to convert the tRNA to 
serine identity. Adapted from (1). 
Figure 2. Mutant I.SM6 
Figure 3. Mutant I.SM4 
Figure 4. Mutant LSM11 
Figure 5. Mutant I.SM10 
Figure 6. Mutant LSM12 
Figure 7. Mutant LSM13 
Figure 8. Mutant I.SM9 
Figure 9. Mutant LSM14 
Figure 10. Composite of E. coli serine tRNAs. Nucleotides highly conserved in serine 
tRNAs and not found in tRNA Tyr (su+3) are indicated. 
Figure 11. Mutant Tyr~Ser 1 
Figure 12. Mutant Tyr~ser 2 
Figure 13. Mutant Tyr~Ser 3 
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ABSTRACT 
Amber suppressor genes corresponding to Escherichia coli tRNAPhe and tRNA Cys have 
been constructed for use in amino acid substitution studies as well as protein engineering. 
The genes for either tRNAPheGAA or tRNACysGCA both with the anticodons 5' CfA 3' were 
assembled from four to six oligonucleotides, which were annealed and ligated into a vector. 
The suppressor genes are expressed constitutively from a synthetic promoter, derived from 
the promoter sequence of the E. coli lipoprotein gene. The tRNAPhe suppressor 
(tRNAPhecuA) is 54-100% efficient in vivo, while the tRNACys suppressor (tRNACyscuA) 
is 17-50% efficient. To verify that the suppressors insen the predicted amino acids, both 
genes were used to suppress an amber mutation in a protein coding sequence. N-terminal 
sequence analysis of the resultant proteins revealed that tRNAPhecuA and tRNA CysCUA 
insert phenylalanine and cysteine, respectively. To demonstrate the potential of these 
suppressors, tRNAPheCUA and tRNACyscuA have been used to effect amino acid 
substitutions at specific sites in the E. coli lac repressor. 
INTRODUCTION 
Nonsense suppressor are alleles of tRNA genes altered in the anticodon, resulting in 
insertion of an amino acid in response to a termination codon. These suppressors have 
been important tools in bacterial genetics (1) as well as in the study of recognition of tRNA 
by aminoacyl tRNA synthetase (2). The use of nonsense suppressors also offers exciting 
possibilities for protein engineering, because numerous altered proteins with known amino 
acid changes can be generated easily. By this method, genes containing amber, ochre, or 
opal mutations (resulting in UAG, UAA, or UGA chain-terminating codons, respectively) 
are expressed in mutant strains that produce suppressor tRNAs capable of inserting an 
amino acid in response to the nonsense mutation. Many single amino acid substitutions at 
specified positions in proteins have already been made. For example, nonsense 
suppression has been used to create close to 400 mutant lac repressor proteins, each 
carrying a known amino acid replacement (3). Unfortunately, the range of amino acid 
exchanges made possible by nonsense suppression has been limited by the relatively small 
set of nonsense suppressors available. Until recently, only five different amino acids could 
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be inserted at an amber codon by suppressor tRNAs. The amber suppressor tRNAs that 
have been generated in vivo (supD, supE, supF, and supP), insert serine, glutamine, 
tyrosine, and leucine, respectively, in response to UAG codons. In addition, Murgola and 
coworkers have described a glycine-inserting amber suppressor derived from a series of in 
vivo genetic manipulations (4). [Ochre suppressors operating at reduced efficiencies can 
insert additional amino acids--for instance, supG directs the insertion of lysine at UAA and 
UAG codons (5), but the inefficient suppression greatly limits their utility for generating 
altered proteins.] With the exception of the glycine suppressor described by Murgola, the 
existing amber suppressor alleles arose from a single base change, resulting in the 
anticodon 5' VAG 3' (6-10). Creating new suppressor alleles by standard genetic means is 
unlikely, as virtually every other tRNA requires more than a single base change to yield a 
CUA anticodon. However, advances in oligonucleotide synthesis (11) have made possible 
the in vitro construction of new suppressor tRNAs, which permits us to greatly extend the 
utility of this approach. To expand the available collection of amber suppressors in E. coli, 
we have synthesized the genes for several tRNAs, altering the anticodon to enable 
recognition of UAG (amber) codons. Here we describe the construction of the genes for 
two such suppressor tRNAs, which insert phenylalanine and cysteine at high efficiency. 
and we demonstrate their utility in amino acid substitution studies of the E. coli lac 
repressor. 
METHODS 
Bacteria, Bacteriophage, Media, and Reagents. E. coli strain XAC-1 is F' 
laci373 lacZuJJBamProB+ I p- ~(lacproB)xJJJ nalA, rif, argEam, ara. The Fl phage, IR l 
was obtained from E. Meyerowitz. Indicator plates used for transformations were minimal 
M9 glucose (12) supplemented with ampicillin (lOOug/ml) and the indicator dye 
5-bromo-4-chloro-3-indolyl ~-D-galactopyranoside (40ug/ml). Folic acid and methotrexate 
were purchased from Calbiochem and ICN, respectively. 
Oligonucleotide Synthesis and Purification. Oligonucleotides were synthesized 
on an Applied Biosystems 380A DNA synthesizer. Three to five A260 units of 
oligonucleotide were purified by electrophoresis through a 20% acrylamidenM urea gel, 
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visualized by UV shadowing, excised, and eluted in 0.3 M NaCl, 10mM Tris-HCl, pH 
7.4, 1mM EDTA, 1% phenol, at 370C for 18 hr. The DNA was precipitated and washed 
with ethanol, dried, and resuspended in distilled H20. 
Gene Synthesis. Each oligonucleotide (2ug) was phosphorylated in 70mM Tris-HCl, 
pH 7.6, lOmM MgC12, 5mM dithiothreitol (DTT), 100uM ATP, with 4 units of 
polynucleotide kinase for 1 hr at 370C. The phosphorylated oligonucleotides (80 pmol 
each) were mixed together in 100mM NaCl, heated to 800C for 5 min, then allowed to cool 
to room temperature over a period of 3 hr. The entire mixture was combined with vector 
pGFIB-1 (previously cleaved with Eco RI and Pst I) to give' a· mass ratio of 10: 1 
(insert:vector). Subsequent ligation was carried out in 50mM Tris-HCl, pH 7.6, 10mM 
MgC12, 20 mM (DTT), 50mM NaCl, 1mM A TP, bovine serum albumin (50ug/ml), with 1 
unit of T4 DNA ligase at 150C for 12 hr. The ligation mixture was used to transform 
competent E. coli XAC-1 cells. From purified colonies exhibiting the suppressor 
phenotype on indicator medium, single-stranded DNA was made by using the F1 phage 
IR1 as helper (13) and sequenced by the chain-termination method of Sanger et al. (14). 
Protein Purification. Purification of mutant dihydrofolate reductase (DHFR) protein 
was carried out by a combination of the methods ofBaccanari et al. (15-17) and is briefly 
described here. E. coli XAC-1 carrying plasmid pDA3-12:Phe was cultured in 61iters of 
minimal M9 glucose medium supplemented with ampicillin (50ug/ml) at 37oc with aeration 
for 18 hr. Cells were harvested and lysed (15) and the crude lysate was extracted with 
ammonium sulfate to 90% saturation (16). The precipitate was brought to a protein 
concentration of 20 mg/ml, 3 m1 of methotrexate Sepharose was added, and the mixture 
was dialyzed for 18 hr (16). The resin was batch-washed (17) and the DHFR was eluted 
with folic acid (17). At this point, the DHFR was 99% pure as judged by silver staining 
(18) of sodium dodecyl sulfate/polyacrylamide gels (19). To remove folate and nucleic 
acid, peak fractions were first dialyzed against 50 mM potassium phosphate, pH 8.0, 1 
mM DDT, and then applied to a DEAE-Sephacel (Pharmacia) column (1 mg/ml protein) 
equilibrated with the same buffer. DHFR was eluted in a linear gradient of 0-0.4M KCl in 
50mM potassium phosphate, pH 8.0, 1mM DTT. Peak fractions were pooled, dialyzed 
against water, and lyophilized. 
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Protein Sequencing. Mutant DHFR protein was sequenced on an Applied Biosystems 
Model470A gas-phase protein sequenator (20) by the USC Microchemical Core 
Laboratory. Mutant ~-galactosidase was purified (21) and sequenced by A. Fowler 
(University of Los Angeles). 
RESULTS 
Gene Construction. The sequences of E. coli tRNAPheaAA and tRNACysGCA with the 
alterations necessary to convert them to amber suppressor tRNAs are shown in Figure 1. 
The synthetic genes for tRNAPheCUA and tRNA CysCUA are depicted in Figure 2. Each gene 
is constructed from a set of 4-6 complementary oligonucleotides ranging in size from 23 to 
46 mucleotides, with 7 -base pair (bp) overlaps at the junctions. Each tRNA gene sequence 
is flanked at the 5' and 3' ends by Eco RI and Pst I sites, respectively. Since the E. coli 
cellular nucleases that process tRNA precursors recognize conserved structural elements 
within the tRNA and not surrounding sequences (25), we expected that these constructs 
would produce fully processed functional tRNAs. 
The oligonucleotides were annealed and ligated into the Eco RI-Pst I sites of plasmid 
pGFIB-1 as described in the Methods section. In this vector (Figure 3), the tRNA gene is 
expressed constitutively from a strong synthetic promoter, based on the promoter sequence 
of the E. coli lipoprotein gene lpp (26). Distal to the promoter and restriction site 
polylinker is a transcription terminator, which we have synthesized based on the 
termination sequence of the ribosomal RNA operon rrnC (27-28). Plasmid pGFIB-I also 
carries the F1 intergenic region, which in the presence of F1 helper phage allows the 
production of single-stranded DNA (13), thus facilitating dideoxy sequencing of the 
synthetic gene. 
To clone active suppressors, the ligation mixtures pGffi :Phe and pGFffi:Cys were 
transformed into E. coli stain XAC-1. This strain carries an F' lac proB episome with an 
amber mutation early in the lacZ gene. In an sup- strain, virtually no active ~-galactosidase 
(the lacZ gene product) is formed. Suppression of the amber mutation should yield 
functional ~-galactosidase, resulting in blue colonies on medium containing the indicator 
5-bromo-4-chloro-3-indolyl ~-D-galactopyranoside. When XAC-1 was transformed with 
pGFIB:Phe or pGFIB:Cys, on average, 60% of the transformants were blue. To confmn 
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that this phenotype was plasmid encoded and not due to spontaneous reversion of the 
amber mutation, plasmid DNA was isolated from transformants that gave blue colonies and 
sequenced to ensure that there were no sequence anomalies in the synthetic construct. 
Determination of Suppression Efficiency. We have exploited the properties of a 
lac/ -Z fusion system, to measure the efficiency of suppression. In this system, the lac/ and 
Z genes are fused, resulting in a hybrid protein with full ~-galactosidase activity (29). The 
N-terminal, /-encoded portion of the fusion is not required for ~-galactosidase activity, 
although continued transcription and translation through this portion of the fusion is 
necessary. Thus, the introduction of nonsense mutations that interrupt translation of the I 
portion of the message results in negligible ~-galactosidase synthesis, while suppression of 
these nonsense mutations restores ~-galactosidase synthesis. As fi-galactosidase activity is 
independent of the nature of the amino acid being insetted into the /-encoded portion of the 
hybrid protein and dependent only on the degree of transmission through the translation 
block, the level of ~-galactosidase activity is a direct measure of the efficiency of 
suppression. Previous studies of suppression at different nonsense sites have shown that 
the efficiency of suppression is dependent on the sequence immediately surrounding the 
nonsense site; the two bases 3' to the nonsense site are especially important (29, 30). 
Generally, amber codons followed by an A or G are suppressed more efficiently than those 
followed by a C or U, although codons followed by the sequence CU are well-suppressed. 
We have examined tRNAPhecuAand tRNACysCUA against a set of ambers in the 
lacl-Z fusion by assaying ~-galactosidase activity of the suppressed fusion protein (12). 
Table I shows the relative efficiency of the new suppressors as well as those for other 
suppressors. tRNAPheCUA has a suppression efficiency of 54-100%, while the efficiency of 
tRNA CyscuA ranges from 17% to 50%, depending upon the context of the amber codon. 
Determination of Suppressor Specificity. A single change in the anticodon of E. 
coli tRNATrpresults in mischarging by the glutamine aminoacyl tRNA synthetase (31). 
Similarly, alteration of the anticodon of E. coli tRNAMet(f) results in mischarging by the 
glutamine synthetase (32-34). Given these precedents, we designed an assay to show 
directly that the new suppressors actually insen the predicted amino acid. tRNAPheCUA and 
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tRNA CysCUA were each used to suppress an amber mutation in a protein-coding sequence. 
The resulting altered proteins were subsequently isolated and subjected toN-terminal 
sequence analysis to determine which amino acid(s) had been inserted in response to the 
amber codon. 
For the determination of the specificity of tRNAPhecuA, we constructed an amber 
mutation via oligonucleotide-directed mutagenesis, in the lOth residue (valine) of the E. coli 
fol gene encoding DHFR (35) (Figure 4). DHFR was chosen because it can be purified in 
virtually one step by methotrexate affmity chromatography. Furthermore, the structure of 
DHFR has been well-delineated by X-ray crystallography (39-41). The tenth residue of 
this protein is not highly conserved throughout phyla and is not in close proximity to the 
active site. Hence, we predicted that substitutions at this site would not significantly alter 
the protein's activity or its behavior during purification. We also converted the 11th 
residue from Asp to Asn. The purpose of this GAT to AA T conversion was to provide a 
better context for the amber mutation. Subsequently, we constructed a plasmid 
(pDA3-12:Phe) that carries both thefol amber gene under the control of the tac promoter 
(38) and tRNAPheCUA flanked by the lipoprotein promoter and rrnC terminator (Figure 4). 
DHFR was isolated from XAC-1 cells harboring this plasmid and subjected to Edman 
degradation on an automated protein sequenator (20). In Figure 5, the picomolar yields of 
phenylthiohydantoin-derivatized phenylalanine, valine, asparagine, and aspartic acid are 
plotted versus the residue number. It should be noted that the wild-type copy of the fol 
gene is also present in the host chromosome. Under control of the rae promoter, the 
plasmid-borne/of gene overproduces DHFR approximately 100-fold above the level 
produced from the chromosomal copy. This should result in minimal levels of Vas-Asp at 
positions 10 and 11 (compared with Phe-Asn) in the presence of a strong suppressor such 
as tRNAPheCUA· The major amino acid at position 10 is indeed phenylalanine, and no other 
amino acids are detected at a significant level, including valine or glutamine. In other 
studies, we have been able to detect 10% insertion of an amino acid at residue 10 (28). 
Therefore, to our limits of detection, phenylalanine is the sole amino acid inserted by the 
new suppressor. Residue 11 is predominantly asparagine, with a trace amount of aspartic 
acid. This may be the result of deamidation of asparagine or due to wild-type background. 
The specificity of tRNACysCUA was determined by A. Fowler in a similar fashion 
(personal communication). The synthetic tRNACysCUA gene was used to suppress an 
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amber mutation located at residue 17 in the lacZ gene. The resulting ~-galactosidase was 
purified and subjected toN-terminal sequence analysis. Cysteine is the major amino acid 
inserted at this site, and again glutamine is not detected at a significant level (data not 
shown). 
Substitutions in the lac Repressor. To demonstrate the potential of the new 
suppressors for structure function studies, we have used them to generate specific amino 
acid replacements in the E. coli lac repressor. The lac repressor is especially suited to 
amino acid substitution studies as its properties are well-understood, its activity is readily 
assayed, and a large number of amber mutations in the repressor gene, lacl, have been 
generated(42). We have previously described the use of suppressed nonsense mutations to 
generate altered lac repressor molecules (3). Close to 90 different nonsense sites in the lac! 
gene have been described, and the ability to add different amino acids by suppression 
offers the opportunity to study a heirarchy of amino acid substitutions at each site. Table IT 
shows several positions in the repressor that are particularly sensitive to certain amino acid 
substitutions. These data can yield useful information regarding the nature of the amino 
acid being inserted by the new suppressors. For instance, glutamine is the wild-type 
residue at positions 18 and 248. From Table 2 it is evident that these sites specifically 
require glutamine among the amino acids examined so far. Exchanges at position 18 affect 
operator binding, and substitutions at position 248 affect inducer binding (the 15 
phenotype). These two sites can be used to determine whether a suppressor is inserting 
glutamine. Also, the phenylalanine at position 293 is not easily replaced without affecting 
the activity of the protein. Note that the phenylalanine-inserting suppressor restores the 
wild-type character, reinforcing the protein chemistry results for this suppressor. In 
addition, the tyrosines at position 17, 47, and 282, and the tryptophan at position 201 are 
sensitive to substitution. Only certain hydrophobic amino acids are allowed at positions 
201 and 282, and the phenylalanine-inserting suppressor does restore activity in both 
cases. None of the previous substitutions for tyrosine at position 47 could restore even 
partial activity. However, as can be seen from Table 2, the phenylalanine-inserting 
suppressor can substitute reasonably well. Possibly, the ring moiety of the tyrosine is 
crucial at this position, and the phenylalanine fulfills a similar function. We note that 
phenylalanine cannot substitute for tyrosine at position 17, a residue that has been 
implicated in operator binding mediated by hydrogen bonding (43). This would be 
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expected, because the phenylalanine ring lacks the hydroxyl side chain of tyrosine that 
could participate in hydrogen bonding. 
DISCUSSION 
Nonsense suppressors can be generated by altering the anticodon of a tRNA to allow 
recognition of chain-termination codons. This approach has already met with success in 
several cases via oligonucleotide-directed mutagenesis (44-47). 
We have described the construction of two amber suppressor tRNA genes, 
tRNAPhecuA and tRNACysCUA• which insert the predicted amino acid at a high level of 
efficiency. By using the approach of total gene synthesis, we have been able to construct 
these suppressor genes very rapidly. Furthermore, the manner in which the genes are 
designed, i.e., without their natural 5' and 3' flanking sequences, does not preclude the 
synthesis of a functional tRNA. We have subsequently assembled the genes for several 
other suppressor tRNAs in an effort to create as large a "bank" of amber suppressors as 
possible (unpublished results). One potential obstacle to creating a complete collection of 
amber suppressors is the possibility that the anticodon of certain tRNAs is crucial for 
recognition by its cognate aminoacyl tRNA synthetase. We therefore developed an assay 
that would enable us to determine whether the anticodon had affected the specificity of the 
tRNA in question, by showing directly which amino acid it inserts into an amber site of a 
protein coding sequence. From these protein chemistry studies, it is evident that the new 
suppressors insert only the original amino acids, phenylalanine and cysteine, at least to the 
limits of detection of the protein sequencing systems. Data from amino acid replacement 
studies in the lac repressor, utilizing tRNAPheCUA and tRNACyscuA. support this 
conclusion. To extend the sensitivity of detection beyond the limits of protein sequencing, 
genetic systems similar to the one featured in Table 2 can be developed further. 
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Table 1. Suppression of amber mutations in a lac/ -Z fusion. 
~-Galactosidase activity,% of wild type 
Suppressor 021c A30 028c A26 A16 017c 013c 
tRNAPheCUA 79 100 78 100 78 54 84 
tRNACysCUA 34 53 50 51 35 17 35 
supD 27 54 32 25 21 6 26 
supE 15 26 10 11 10 0.8 11 
supF 34 67 62 100 43 11 46 
supP 72 70 80 100 62 30 58 
All assays were carried out at 37°C and were determined in duplicate (12). Values are 
given as the percentage of the wild-type fusion in the respective suppressor strains. Values· 
for supD, supE, supF, and supP are taken from Miller and Albertini (29). 
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Table 2. Amino acid substitutions in the lac repressor. 
Replacement by suppression 
Wild-type 
residue Ser Gin Tyr Leu Phe Cys 
Tyr-17 +I- -I+ + -1+ -I+ -I+ 
Try-47 + +I-
Tyr-282 + + + 
Trp-210 + + 
Phe-293 +I- +I- s s + s 
Gln-18 + -I+ 
Gln-248 s + s s s s 
+,Normal activity; s, DNA binding activity retained but not inducibility;-, no activity, 
presumably because of defects in folding, aggregation or DNA binding. Partial activities: 
+/-indicates a less severe defect that-/+. 
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FIGURE LEGENDS 
Figure 1. RNA sequences of E. coli tRNAPheGAA (22) and tRNACysGCA (23) with the 
base changes that would enable the tRNAs to recognize amber codons. 
Figure 2. Synthetic genes for tRNAPheCUA and tRNA CysCUA· The first and last 
nucleotides encoding each tRNA (indicated by a dot) are immediately flanked by the 
cohesive ends of Eco RI and Pst I restriction endonuclease sites, respectively. Arrows 
indicate the oligonucleotide junctions, and the altered anticodon is underlined. Note that the 
tRNAPheCUA gene does not encode the 3'-tenninal C and A residues. These residues are 
added in vivo by tRNA nucleotidyltransferase (24). 
Figure 3. Plasmid pGFIB-1. This vector is a derivative ofpEMBL8+ (13). We have 
replaced the lac promoter with a synthetically constructed promoter ( 48) based upon the 
promoter sequence of the E. coli lipoprotein gene lpp (26). Two complementary 
oligonucleotides encoding a transcription termination sequence from the E. coli "nC 
operon (27) have been ligated into the Pst I and Hind ill site of the poly linker (28). The 
oligonucleotides encoding the tRNA genes are ligated into the Eco RI and Pst I sites of the 
poly linker. 
Figure 4. Construction of plasmid pDa3-12. Oligonucleotide-directed mutagenesis (36) 
was carried out on the E. colifol gene (35) encoded by a 1-k:ilobase fragment contained in 
the vector M13mp8 (37). Plasmid pDa3-12:sup tRNA, in this case pDa3-12:Phe, was 
constructed by a series of subcloning steps. The 247-bp Eco RI-Hind ill fragment of 
pTAC12H (38) containing the tac promoter was ligated into the Eco RI-Hind ill sites of 
pBR322 to create pTAClO. Subsequently, the DHFR amber encoded by a 1057-bp Hind 
ill fragment, was subcloned into the Hind ill site ofpTAClO, which yielded pDa3-12. 
The 350 bp Pvu il fragment from pGFIB:Phe containing the lipoprotein promoter, 
tRNAPhecuA, and the "nC terminator was ligated into pDa3-12 to yield pDa3-12:Phe. 
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Figure 5. The picomolar yields ofphenylthiohydantoin-derivatized phenylalanine, valine, 
asparagine, and aspartic acid have been plotted versus the residue number for DHFR 
purified from E. coli XAC-1 cells carrying pDa3-12:Phe. 
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Construction of Escherichia coli amber suppressor genes: Optimization of 
suppressor efficiency and determination of tRNA specificity 
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The work described herein was carried out in collaboration with Jeffrey H. Miller, 
Lynn G. Kleina, and Jean-Michel Masson; two other manuscripts detailing parts of this 
work are in preparation. 
ABSTRACT 
Using synthetic oligonucleotides, we have constructed a collection of E. coli amber 
suppressor tRNA genes (1, 2). These suppressors vary in efficiency, and we have been 
able to increase the suppression efficiency for some of the tRNAs via mutagenesis. In 
order to determine the specificity of these tRNAs, each was used to suppress an amber 
(UAG) nonsense mutation in the E. coli dihydrofolate reductase genefol. The mutant 
proteins were purified and subjected toN-terminal sequence analysis to determine which 
amino acid had been inserted by the suppressor tRNAs at the position of the amber codon. 
The suppressors can be classified into three groups, based upon the protein sequence 
information. Class I suppressors, tRNAA1a2cuA, tRNAGlyUCUA, tRNAHisACUA, 
tRNALysCUA· and tRNAProHCUA· inserted the predicted amino acid. The Class II 
suppressors, tRNAGluACUA, tRNAGlyTCUA· and tRNAllelCUA were either partially or 
predominantly mischarged by the glutamine aminoacyl tRNA synthetase (AAS). The Class 
III suppressors, tRNAArgCUA, tRNAAspMcuA, tRNAile2cuA, tRNAThr2cuA, 
tRNAMet(m)CUA and tRNA ValCUA inserted predominantly lysine. 
INTRODUCTION 
We have set out to construct a complete collection of E. coli amber suppressor tRNA genes 
for use in studies of protein structure and function. We previously reported the 
construction of amber suppressor alleles of E. coli tRNAPhe and tRNACys from synthetic 
oligonucleotides (3). Subsequently, we have constructed amber suppressor alleles for an 
additionall5 tRNAs in a similar fashion (1, 2). These tRNAs, each with a CUA anticodon 
to enable recognition of amber codons, are constitutively expressed from a high copy 
number plasmid (4, 5). Table 1lists the suppression efficiencies of the newly generated 
tRNAs. For a number of the amber suppressor tRNAs the suppression efficiencies were 
so low that they would not be useful in amino acid substitution studies. We undertook to 
improve the suppression efficiencies of a number of the tRNAs by several means. 
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I. Optimization of suppressor efficiency 
Different lsoacceptors. We found that in some cases, the amber suppressor 
efficiencies varied among isoacceptors of a given tRNA species. This was the case for 
alanine, isoleucine, threonine and valine tRNAs. tRNAAlalcuA, tRNAilelcuA, 
tRNAThrlCUA• and tRNAVallcuA were all non-functional suppressors as evidenced by their 
very low suppression efficiencies. Simply generating an amber allele of a different 
isoacceptor for these tRNAs resulted in suppressor tRNAs which were significantly more 
efficient (Table 1). Subsequent to generating the Alal suppressor, we learned that the 
published sequence, which the tRNA gene was based on, was in question. The fact that 
the sequence is incorrect would help to explain why the Alal suppressor was inefficient. 
We do not know if the same holds for the other inefficient tRNAs. 
The Extended Anticodon Hypothesis. The extended anticodon hypothesis put forth 
by Y arus ( 6) states that " ... the structures of the anticodon loop and the proximal 
anticodon stem are related to the sequence of the anticodon." Comparison of the anticodon 
stem and loop sequences from E. coli tRNAs reveals that they are related to the 3' 
nucleotide of the anticodon, referred to as the cardinal nucleotide. Put another way, for a 
given nucleotide at the 3' position of the anticodon, the sequence of the anticodon stem and 
loop (the extended anticodon) will have a predictable sequence. These fmdings are 
applicable to suppression efficiency in the following manner. To generate an amber 
suppressor allele, it is necessary to alter the anticodon to CUA, by one or more base 
changes. Y arus noted that for weak amber suppressors the mutations necessary to render 
an amber suppressor resided in the cardinal nucleotide, while strong amber suppressors did 
not have an alteration in the cardinal nucleotide. According to the extended anticodon 
hypothesis, when the cardinal nucleotide is altered as in the case of the weak suppressors, 
the proximal anticodon stem and loop sequences are no longer related to the cardinal 
nucleotide, resulting in decreased translational efficiency. To generate the aspartic acid 
suppressor, the cardinal nucleotide was altered from C to A, and the resultant suppressor 
was non-functional. Based upon the consensus sequences that were derived for each of the 
four possible cardinal nucleotides, the extended anticodon of tRNAAsPcuA suppressor 
deviated at five positions. Using oligonucleotide-directed mutagenesis, we altered those 
five nucleotides so that the extended anticodon would conform to the 
consenesus sequence for a cardinal nucleotide of "A." The resultant tRNA, tRNAAspMCUA· 
was tenfold more efficient than the original tRNAAsPcUA· 
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3' Double A. The extended anticodon hypothesis dictates that if the cardinal nucleotide is 
an A, the two 3' proximal nucleotides (37 and 38) should be A as well. Position 37 of the 
glutamic acid and histidine suppressors, both fairly weak, was changed to A, resulting in a 
two- to sixteen-fold increase in suppression efficiency (Table 1). It should be noted that in 
generating tRNAAla2cuA, the alternate alanine isoacceptor, position 37 was changed to an A 
as well. 
The Hybrid Molecule Approach. While the proline amber suppressor is 
non-functional ( < 1% efficient), the phenylalanine amber suppressor is very strong 
( 48-100% ). Speculating that the anticodon stem and loop do not play a role in proline AAS 
recognition, we generatd a tRNA variant (via gene synthesis) with the anticodon stem and 
loop region of tRNAPheCUA and the remaining regions of the tRNA from tRNAPro. This 
mutant, tRNAProHCUA had a suppression efficiency ranging from 8 to 60%. 
In summary, using the above approaches we were able to generate amber suppressor 
tRNAs for 14 species oftRNA that had reasonably high suppression efficiencies, from 6 to 
100%, depending upon the context of the amber codon being suppressed (Table 1). We 
have not yet been able to generate an efficient suppressor allele for tRNAAsn. 
II. Determination of tRNA specificity 
The anticodon of a tRNA potentially plays a role in the recognition of the tRNA by its 
cognate aminoacyl tRNA synthetase (AAS). For example, altering the anticodon of the 
tryptophan or formyl-methionine tRNAs from E. coli, results in mischarging by the 
glutamine AAS (7 -1 0). Chemical modification of the E. coli tRNA Arg or yeast tRNA Phe 
anticodons reduces cognate aminoacylation in vitro (11-14). It was possible, then, that the 
amber suppressor alleles that we had constructed would have altered specificity, i.e., the 
recognition of these tRNAs by their cognate AAS would be affected by the change 
introduced into the anticodon. Determining the amino acid specificity of the newly 
constructed suppressor tRNAs would reveal the extent to which the anticodon plays a role 
in AAS recognition for each of these tRNAs. Previously, we reported the development of 
a specificity assay in which a tRNA was used to suppress an amber mutation in the tenth 
residue of the E. coli dihydrofolate reductase (DHFR) genefol. The mutant protein was 
subsequently purified and partly sequenced to determine which amino acid the suppressor 
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tRNA had inserted at the amber codon (3, 5). In this paper we present the results of the 
specificity assays for the 14 new suppressor tRNAs. 
METHODS 
Bacterial Strains and Media. All strains were derived from E. coli XAC which is F-
!i(lacproB)xln• na/A, rif, argEam, ara. XACRF is XAC with uar and tnlO transduced into 
the chromosome. The episome (laci373lacZuzl8amProB+) is designated II -1 II as in XAC-1 
and XACRF-1. The episome (lacH'zyAtn5) is designated 119100.111 and is found in 
XAC/9100.1 and XACRF/9100.1. The episome Zmet3 is (lacllacZam3) and is found in 
XAC/Zmet3. Minimal M9 media was prepared according to Miller (15) and supplemented 
with 100ug/ml ampicillin, and 30ug/ml chloramphenicol, both from Sigma. L broth was 
10g/l Bactotryptone, 5g/l yeast extract, and 8g/l NaCl. 
Plasmid Construction. Plasmid pDA3-12 (3, 5) contains the coding region of the E . 
coli DHFR gene fol with an amber mutation at residue ten ifofamlO), under control of the 
tac promoter, cloned into the Eco RI-Hind III sites of pBR322. pDA3-12:Arg was 
constructed by subcloning the Pvu II fragment ofpGFIB:Arg (1), which carries the 
tRNAArgCUA gene expressed from the lpp promoter, and followed by the rrnC 
transcription terminator, into the Pvu II site of plasmid pDA3-12 (Figure 1a). 
pDA3-12:AspM, pDA3-12:lle2, pDA3-12:Thr2, and pDA3-12:Val were constructed in a 
similar fashion. To construct plasmid pDA5YC, a Hind ll-Eco RI adaptor was ligated to 
the Eco RI cohesive end of the Eco RI-Bam HI fragment of pDA3-12, and subcloned into 
the Hind III-Bam HI sites of plasmid pACYC184 (Figure 1b). Plasmid pDAYQ was 
constructed by attaching Sal I linkers to the Eco RI fragment from plasmid pJWlaci (16), 
which carries lacH, and ligating the entire fragment into the Sal I site ofpDA5YC (Figure 
1b). 
All of the suppressor tRNA genes were subcloned into wild type lambda in the 
following manner. Xba I or Sal I linkers were ligated to the Pvu II fragment of each of the 
pGIB:suptRNAs (1, 2), which carries the tRNA gene, along with the lpp promoter and a 
transcription terminator. The linkered fragment was then ligated into the single Xba I site 
of wild type lambda (Figure 1c ). Cloning techniques were as described by Davis et al. 
(17). Phage constructs containing only a single copy of the suppressor tRNA gene were 
used to lysogenize E. coli strains. 
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Purification ofDHFR. XAC-1 or XACRF-1 carrying both pGFIB:sup and pDAYQ; 
XAC/9100.1 or XACRF/9100.1 carrying pGFIB:sup and pDA5YC; XAC/9100.1 or 
XACRF/9100.1 carrying pDA3-12:suptRNA alone, were all cultured in minimal M9 media 
supplemented with ampicillin (chloramphenicol was added in the presence of plasmids 
pDA5YC orpDAYQ) to an A600 of0.5 to 0.7. The cell cultures were diluted 100 fold into 
fresh minimal media, grown to an A600 of0.4 to 0.6, at which time thefol gene was 
induced with isopropyl thiogalactoside (IPTG) at a final concentration of lmM, for 4 to 18 
hr. Alternatively, XAC/9100.1 or XACRF/9100.1, which had been lysogenized with the 
lambda suppressor constructs and transformed with plasmid pDA3-12, were cultured and 
induced as above except that L broth supplemented with ampicillin was used instead of 
minimal medium. The cells were harvested, and DHFR was purified as described by 
Normanly et al. (3, 5) with only one notable change. A MonoQ column (Pharmacia) was 
used interchangeably with a DEAE-sephacel column (Pharmacia) in the final stage of the 
purification. Purified DHFR was subjected to N-terminal sequence analysis at the USC 
Microchemical Core Facility or the Caltech Microchemical Facility. 
Purification of ~-galactosidase. Srain XAC/Zmet3 carrying pGFIB:Val was 
cultured in minimal media as described for the purification of DHFR except that the IPTG 
induction was eliminated. Cells were harvested and frozen at -200C. Subsequent steps 
were carried out on ice with stirring. The cell pellet was thawed in 2.14 ml/ g cells TEP 
(lOOmM Tris HCl, pH 7 .4, lOmM EDTA, lmM phenylmethylsulfonyl fluoride, PMSF). 
The following additions were made at 30 min. intervals: (1) 0.15 ml/g cells of lysozyme 
(17mglml in TEP); (2) 0.055 ml/g cells of 1M MgC12 and 0.015 ml/g cells of DNasei (13.2 
mglml in TEP). The suspension was centrifuged at 12,000 x g for 15 min. at 4°C. The 
supernatant was saved and the pellet resuspended in 2.14 ml/g cells TEP. Steps 1 and 2 
were repeated and the suspension centrifuged as above. The pellet was washed with 
0.92ml!g cells TEP and centrifuged again. All three supernatants were pooled, brought to 
40% saturation with ammonium sulfate and stirred on ice for 2 hr. The suspension was 
centrifuged at 19,000 x g for 30 min. at 4°C. The precipitate was resuspended in lml of 
TEP, and brought to a concentration of 4 mglml with TBSN ( lOmM Tris HCl, pH 8.0, 
150mM NaCl, 0.2% NP-40). The suspension was equilibrated with lml ofPromega Proto 
Sorb Lac Z column matrix, batch washed with TBSN, and applied to a column. 
~-galactosidase was eluted from the column with 100mM Na-Carbonate buffer, pH 
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10.8, according to the manufacturers instructions. Purified beta-galactosidase was dialyzed 
against distilled water, lyophilized and sequenced at the USC Microchemical Core Facility. 
RESULTS 
In order to determine the specificity of the amber suppressor tRNAs, we constructed strains 
which carried both the suppressor tRNA gene to be assayed andjo[amiO. We used three 
different methods to create these strains. In one case the suppressor tRNA gene and 
jo[amiO were carried on the same plasmid. In another case,jo[amlO resided on a plasmid, 
while the suppressor tRNA gene was integrated into the chromosome on a lambda 
prophage. Last, both the suppressor tRNA gene andjo[amiO were carried on separate, 
compatible plasmids. We used the E. coli strains, XAC and XACRF, which differ in two 
genetic markers. XACRF was derived from XAC by transduction of uarts (linked to tn10), 
into the chromosome. The uarts allele is a release factor mutant. Its effect is to enhance 
suppression efficiency, because the release factor competes poorly with the suppressor 
tRNA for the nonsense codon. This strain was employed for those suppressor tRNAs with 
lower efficiencies. 
Single Plasmid System. Previously, we described the plasmid pDA3-12, which 
carriesjo[amlO under control of the tac promoter (3, 5). The suppressor alleles 
corresponding to tRNAs Ile2, Val, AspM, Thr2, and Arg (1, 2) were subcloned into the 
pDA3-12 vector (Figure 1a). 
Lambda Prophage and Plasmid Encodedfol Amber. We have found the 
plasmids encoding suppressor tRNAs to be somewhat unstable unless suppression is 
required for growth. The instability is probably due to the high copy number of the vector 
(pGFIB-1) and the fact that the suppressor genes are expressed constitutively (1, 4). The 
E. coli strain XAC has an amber mutation in the ArgE operon, which will accept a variety 
of amino acids. Consequently, if the suppressor-carrying strains are maintained on 
minimal media, the plasmids are stable. Our long term goal is to compile a collection of 
suppressor tRNA genes, which can be used in any strain background. We speculated that if 
the suppressor genes were present in lower copy number they would be more stable and 
would not require the ArgE background. Additionally, we wished to determine the effect 
of lowered copy number on the suppression efficiency of the tRNAs. We cloned 13 of the 
suppressor tRNAs genes, expressed from a constitutive promoter, lpp, (4) and followed by 
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a transcription tenninator, rrnC (3, 5), into the single Xba I site of wild type lambda. 
These phage constructs were integrated into the chromosome of E. coli strain XAC and 
various derivatives, and the suppressor tRNAs were assayed for efficiency (data not 
shown) using the Lacl am-Z system of Miller (18). It was clear that the copy number of 
these tRNA genes played an important role in their suppression efficiencies. Of the 13 
suppressor-carrying prophage, only those encoding tRNAGlyTCUA· tRNAHisACUA and 
tRNAAla2CUA had suppression efficiencies high enough to render the tRNAs useful in 
amino acid substitution studies (data not shown). These strains were transformed with 
plasmid pDA3-12, which encodesjo[amlO, for the specificity assay (Figure 1b). 
Compatible Plasmid System. We also developed a system wherein the suppressor 
tRNA gene resided in pGFIB-1, andjo[amlO was carried on a compatible plasmid. We 
subcloned thejo[amJO gene into the Hind III-Bam HI site of pACYC184 to yield pDA5YC 
(Figure 1c ). Because jo[amJO is under tac promoter control, it is necessary to maintain the 
plasmid in an lacJq strain (19). For added flexibility, we subcloned the lacH gene into 
plasmid pDA5YC to yield plasmid pDA YQ (Figure 1c). 
Suppressors for tRNAs Ilel, Ile2, Arg, AspM, Val, Thr2, ProH, Met(m), Lys, GluA 
and GlyU were transformed into either strains (XAC-1 or XACRF-1) carrying plasmid 
pDAYQ or strains (XAC/9100.1 or XACRF/9100.1) carrying plasmid pDA5YC. The cells 
were cultured in minimal media, and after induction of the fa/ gene with IPTG, DHFR was 
purified from these cells by affinity chromatography. N-tenninal sequence analysis of the 
purified proteins revealed which amino acid(s) had been inserted in response to the amber 
codon by each suppressor tRNA. 
Protein Sequence Data. Figure 2 shows the results from the protein sequencing. 
tRNAAla2CUA• tRNAHisACUA• tRNALysCUA• and tRNAProHCUA all inserted the predicted 
amino acid exclusively (Figure 2a). Interestingly, two different isoacceptors of tRNA Gly 
behaved differently when their anticodons were altered to CUA. tRNAGlyUCUA inserted 
exclusively glycine, while tRNAGlyTCUA inserted a mixture of glycine (62%) and glutamine 
(37%) (Figure 2b). Similar results for the GlyT suppressor have been obtained elsewhere 
(20). The glutamic acid suppressor tRNA GluACUA inserted mostly glutamic acid (59%) but 
was mischarged by the glutamine AAS as well (17%). One isoacceptor of tRNAlle, 
tRNAllelCUA· was mischarged by the glutamine AAS (74%) and to some extent by the 
lysine AAS (16% ), while another isoacceptor of lie, tRNAlle2cuA. was mischarged 
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exclusively by the lysine AAS (Figure 2b). Five other suppressor alleles, tRNAArgcuA, 
tRNAAspMCUA' tRNAMet(m)CUA, tRNAThr2cuA, and tRNAValCUA were mischarged by the 
lysine AAS (Figure 2c). In the cases of tRNAArgCUA· tRNA Thr2cuA. and tRNA Va!CUA, 
some of the predicted amino acid was inserted as well, but not more than 10%. The average 
background level for any amino acid residue is approximately 3%. Amino acid levels of 
5% and above were considered significant. The percent amino acid incorporated into 
protein may not add up to 100%, because background levels are not included. For 
example, while proline is the major amino acid inserted by tRNAProHcuA, and no more than 
3% of any other amino acid was found, the value given for percent proline incorporated 
into protein is only 85%. 
As stated in the introduction, there is precedent for mischarging by the glutamine 
AAS when the anticodon is altered; however, mischarging of a tRNA by the lysine AAS 
was completely unexpected. Since we began this work others have observed mischarging 
by the lysine AAS (21). The existence of a second lysine AAS in E. coli, which is a heat 
shock protein, may explain the lysine mischarging (22). It occurred to us that the 
overproduction of DHFR might induce a heat shock response and cause mischarging by the 
lysine AAS. To rule out this possibility, we decided to assay the specificity of tRNA VaiCUA 
using another protein. We chose a mutant of the LacZ gene, with an amber mutation 
residing in the third residue. This gene is encoded episomally, and ~-galactosidase is not 
overproduced to the extent that DHFR is. pGFIB:Val was transformed into XAC{Zmet3, 
from which ~-galactosidase was purified. As for the fol amber, lysine was found to be the 
predominant amino acid inserted, with no more than 5% valine shown to be incorporated 
(data not shown). 
DISCUSSION 
We have generated amber functional suppressor alleles for 14 species of tRNA (Table 1), 
and determined their amino acid specificities. Tables 2 and 3 summarize the results. Table 2 
gives the specificities of amber suppressor alleles generated in this work as well as from 
previous work by us and others. With the exception of tRNAAsn, functional supressor 
alleles exist for all tRNA species (and in some cases multiple isoacceptors). The 
specificities of these suppressors are known in vivo for all but tRNAMet(f)cuA, which has 
been examined in vitro (10). The specificity assays conducted upon these tRNAs reveal 
that they may be classified in one of three ways (Table 3). For Class I, altering the 
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anticodon to CUA does not affect cognate AAS recognition in vivo. For the other two 
classes of tRNA, such an alteration results in mischarging by either the glutamine (Class II) 
or lysine (Class ill) AAS. Interestingly, different isoacceptors of a given tRNA species 
may fall into separate classes, as in the case of tRNAllelcuA and tRNAile2cuA, as well as 
tRNAGlyUCUA and tRNAGlyTCUA· 
Our goal to generate a complete bank of amber suppressor tRNA genes has only 
been partially achieved. The suppressors that fall into class I will be useful in amino acid 
substitution studies, and to this end the existing collection of useful amber suppressors has 
been increased from 4 to 11. (A suppressor allele of tRN A GiyU CUA had been generated 
previously by genetic means but the exact specificity was unknown; 23). The tRNAs in 
class II and ill remain an obstacle. It is not clear what distinguishes one class of tRNA 
from another; sequence comparison among the three classes does not reveal any uniquely 
conserved nucleotides. A fortuitous mutation in the tRNAArgCUA suppressor has resulted in 
a variant that inserts exclusively arginine (24), although it is not immediately obvious why 
this is the case. Clearly, if we are to succeed in our goal of generating a complete collection 
of amber suppressor tRNA genes, each inserting the predicted amino acid, we must define 
those elements of class ll and ill tRNAs that dictate cognate AAS recognition. 
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Table 1. Suppression efficiencies of amber suppressor tRNAs. 



























*Suppression efficiencies are a direct measurement of 13-galactosidase activity(% of wild 
type) resulting from suppression of amber mutations in lacl-Z fusions (15). 
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Figure 1a. The Pvu II fragment encoding the amber suppressor tRNA genes, flanked by 
the lpp promoter (4) and rrnC terminator (3), were subcloned into the Pvu II site of plasmid 
pDA3-12 (3). "suptRNA" in pDA3-12:suptRNA is generic, representing each of the 
suppressor tRNA genes that have been subcloned into the plasmid. For example pDA3-12 
carrying the Arg suppressor is actually referred to as pDA3-12:Arg. 
Figure 1 b. Xba I or Sac I linkers were ligated to the Pvu IT fragment shown in Figure 1 a, 
and subcloned into the single Xba I site of wild type lambda DNA. The lambda constructs 
were used to lysogenize E. coli strains, which were then transformed with plasmid 
pDA3-12. 
Figure 1c. pGFIB:suptRNA is derived from plasmid pGFIB-1 (3). Again "suptRNA" is a 
generic term. Plasmid pDA5YC encodes the fol amber and a chloramphenicol resistance 
marker. Plasmid pDA YQ differs from pDA5YC in that the lacH gene is inserted into the Sal 
I site of pDA5YC. The lacH gene overproduces the lac repressor, which is necessary for 
the regulation of the fol gene's tac promoter. With the lacH gene encoded by the same 
plasmid that carries the fol amber, it is not necessary to use an E. coli strain that carries the 
lacH allele chromosomally. 
Figure 2. Protein sequence analysis of DHFR substituted at position ten by the newly 
generated suppressor tRNAs. Sequence analysis was carried out on an Applied 
Biosystems model 470A gas phase sequenator (26) by the USC Microchemical Core 
Laboratory. The picomolar yields ofphenylthiohydantoin (PTH) derivatives of various 
amino acids are plotted against the residue number. The N-terrninal sequence (up to 15 
residues) of the DHFR mutant is indicated below each plot, and the percent yield of the 
amino acid at residue ten is indicated to the right of the plot. Only the most significant 
yields are presented; amino acids not shown can be presumed to be present at background 
levels. Protein sequence results from DHFR substituted at position ten with a) 
tRNAAla2CUA, tRNALysCUA, tRNAProHCUA, and tRNAHisACUA b) tRNAGlyTCUA, 
tRNAGlyUCUA, tRNAGluACUA, and tRNAllelCUA· *Data not shown. c) tRNAlle2cuA, 
tRNAMet(m)CUA, tRNAArgCUA, tRNAAspMCUA, tRNAThr2cuA, and tRNAValCUA· 
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